Introduction {#s1}
============

Transcription factors read DNA-encoded information to control gene transcription and define the complement of proteins a cell can produce. They achieve this by physically binding specific DNA sequence motifs in gene regulatory elements that ultimately control how RNA polymerases engage with and transcribe genes ([@bib63]; [@bib72]). In prokaryotes, transcription factors tend to function as self-contained units that recognize extended DNA sequences with high specificity and affinity ([@bib78]). Therefore, simple sequence-based principles appear to dictate their binding in the genome. In contrast, transcription factors in higher eukaryotes recognize shorter DNA sequences and often interface with other DNA-binding transcription factors in a combinatorial manner to achieve affinity and specificity ([@bib78]; [@bib71]). In addition to the widespread requirement for combinatorial DNA binding, eukaryotic transcription factors are also confronted with the added complexity that eukaryotic DNA is wrapped around histones to form nucleosomes and chromatin ([@bib39]). The association of DNA with nucleosomes can therefore compete with DNA-binding transcription factors, limiting their ability to engage with the genome ([@bib63]; [@bib72]). Indeed, in many cases transcription factor binding appears to require pre-existing chromatin accessibility ([@bib24]; [@bib4]; [@bib36]).

This chromatin barrier therefore poses a significant challenge in establishing new gene regulatory elements when cells differentiate during development. Therefore, to overcome this obstacle, cells have evolved a specialised set of transcription factors that are able to recognise their cognate motifs even when nucleosomes are present ([@bib83]). This is exemplified by the forkhead box A1 (FoxA1) transcription factor, which binds to and de-compacts nucleosomal DNA in vitro ([@bib17]) and in vivo ([@bib33]; [@bib44]; [@bib35]). Based on this type of activity, factors like FoxA1 have been called 'pioneer' transcription factors as they appear to play a primary role in recognizing and shaping how new gene regulatory elements are established in previously inaccessible chromatin ([@bib45]; [@bib83]). Once bound to their target sites, pioneer transcription factors appear to create accessible chromatin ([@bib53]; [@bib57]) that supports the recruitment of non-pioneer transcription factors and the formation of functional gene regulatory elements ([@bib69]; [@bib74]; [@bib23]; [@bib79]; [@bib57]). These unique features of pioneer transcription factors allow them to function as master regulators that underpin developmental transitions, cellular reprogramming, and responses to cellular signalling events.

The capacity of pioneer transcription factors to destabilise or reposition nucleosomes to facilitate chromatin accessibility at their target sites appears to be an essential feature of their activity. Initially, it was proposed that pioneer factors might achieve this by interacting specifically with nucleosomes to alter chromatin structure. For example, FoxA1 and FoxO1 structurally resemble histone H1, which has been proposed to lead to displacement of H1 and destabilisation of neighbouring nucleosomes ([@bib17]; [@bib28]). Alternatively, it has been proposed that ATP-dependent chromatin remodellers may be required to assist pioneer transcription factors in establishing accessible chromatin ([@bib34]; [@bib46]; [@bib10]; [@bib66]). Nevertheless, for most pioneer transcription factors there remains limited understanding of the mechanisms by which they translate their binding within inaccessible and nucleosome-occluded chromatin into effects on chromatin structure that support additional transcription factor binding and gene regulation.

One paradigm that has been used to study pioneer transcription factor function is the cellular reprogramming of somatic cells into induced pluripotent stem cells (iPSC) by the Yamanaka transcription factors (OCT4, SOX2, KLF4, and c-MYC) ([@bib67]). With the exception of c-MYC, these transcription factors are proposed to act as pioneers during cellular reprogramming and can bind their targets sites even when they are occupied by nucleosomes ([@bib61], [@bib62]; [@bib11]). It is thought that this pioneering activity may then pave the way for nucleosome displacement and further transcription factor binding that establishes functional regulatory elements ([@bib81]; [@bib58]; [@bib59]). While it is clear that these transcription factors have the capacity to engage with previously inaccessible regions of chromatin during iPSC reprogramming, it is unknown whether additional mechanisms are required to transition these initial engagement events into functionally mature transcription factor binding as part of the pluripotency-associated regulatory network.

To begin addressing this fundamental gap in our understanding, we have used mouse embryonic stem cells, which exist in an established pluripotent state, as a model system to dissect how the core pluripotency transcription factor OCT4 engages with target sites inside cells. In doing so we discover that OCT4 occupies sites that would otherwise be inaccessible and is required to shape the occupancy of additional pluripotency transcription factors. OCT4 achieves this by recruiting the chromatin remodelling factor BRG1 to support not only its own binding but also to stabilize further transcription factor binding events required to support pluripotency-associated gene regulation. This reveals that although OCT4 can engage with its target sites in inaccessible chromatin, the recruitment of a chromatin remodelling enzyme is a fundamental step in pluripotency transcription factor binding and gene expression. Intriguingly, OCT4-bound regulatory sites that require BRG1 are activated more slowly in response to cellular reprogramming and later during early development. Together these observations reveal that the capacity of OCT4 to cooperate with a chromatin remodeller is a key feature of its pioneering activity, and this is required to mature transcription factor binding and create functional gene regulatory elements.

Results {#s2}
=======

The pioneer factor OCT4 binds distal regulatory sites in pluripotent cells that would otherwise be inaccessible {#s2-1}
---------------------------------------------------------------------------------------------------------------

The atomic structure of OCT4 and its DNA binding activity in vitro have been characterized in detail ([@bib38]; [@bib21]), yet the mechanisms which support how OCT4 functions as a pioneer transcription factor in vivo remain poorly defined. Our current understanding is based largely on overexpression studies during iPSC reprogramming where OCT4 binds a large number of its motifs in inaccessible regions of chromatin ([@bib61], [@bib62]; [@bib11]). However, whether these binding events represent functionally relevant pioneering interactions that precede the creation of accessible chromatin and downstream target gene expression remains largely unknown. We therefore set out to examine how OCT4 engages with and functions at its binding sites in a more physiologically relevant situation in mouse embryonic stems cells (ESCs), where OCT4 plays an essential role in shaping distal regulatory element function and controlling the pluripotent transcriptome. In order to achieve this, we first set out to identify a *bona fide* set of OCT4 binding events in mouse ESCs using chromatin immunoprecipitation coupled with massively parallel sequencing (ChIP-seq). We applied this approach to a conditional mouse ESC line where addition of a small molecule (doxycycline) leads to loss of OCT4 expression ([@bib49]). It is known that prolonged removal of OCT4 in ESCs results in loss of pluripotency and cellular differentiation ([@bib49]; [@bib1]). We therefore identified an acute treatment condition where following 24 hr of doxycycline treatment cells lacked appreciable OCT4 protein ([Figure 1A](#fig1){ref-type="fig"}) but retained normal ESC morphology, were alkaline phosphatase positive, and expressed wild type levels of the pluripotency transcription factors SOX2 and NANOG ([Figure 1A,B](#fig1){ref-type="fig"}). Analysis of our OCT4 ChIP-seq identified 15,920 high-confidence OCT4 binding sites that were lost following doxycycline treatment ([Figure 1C](#fig1){ref-type="fig"}) and were highly enriched for known OCT4 binding motifs ([Figure 1---figure supplement 1A,B](#fig1s1){ref-type="fig"}). The majority of these binding events (75%) correlated with a histone modification signature usually associated with distal regulatory elements (high H3K4me1/low H3K4me3), while only a small subset (6.8%) corresponded to sites with a promoter associated histone modification signature (high H3K4me3/low H3K4me1) ([Figure 1D](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1C,D](#fig1s1){ref-type="fig"}). These observations are consistent with previous reports indicating that OCT4 binds extensively to distal as opposed to promoter proximal regulatory regions in the genome ([@bib14]; [@bib25]). The identification of *bona fide* OCT4 target sites, and the maintenance of stem cell features under these treatment conditions, provided us with an opportunity to examine in more detail where and how OCT4 normally engages with the ESC genome, and to ask how this is related to underlying chromatin accessibility and transcription factor co-occupancy.10.7554/eLife.22631.003Figure 1.OCT4 binds distal regulatory sites in mouse embryonic stems cells to shape chromatin accessibility.(**A**) Western blot analysis of *OCT4^cond^* (ZHBTC4) mouse ESCs before (UNT) and after 24 hr treatment with doxycycline (DOX). (**B**) Alkaline phosphatase staining of *OCT4^cond^* mouse ESCs before (UNT) and after 24 hr DOX treatment. (**C**) A metaplot of OCT4 ChIP-seq signal in *OCT4^cond^* ESCs before (UNT) and after 24 hr DOX treatment at OCT4 peaks (*n* = 15920). (**D**) Annotation of OCT4 peaks as promoters or distal regulatory elements using the relative enrichment of promoter-associated H3K4me3 or distal regulatory element-associated H3K4me1. (**E**) A genomic snapshot of ATAC-seq and OCT4 ChIP-seq signal in *OCT4^cond^* ESCs before (UNT) and after 24 hr DOX treatment at the *Utf1* locus. The downstream OCT4-bound regulatory element is highlighted in the grey box. (**F**) A heatmap illustrating OCT4 targets (*n* = 15920) ranked by their loss of chromatin accessibility (ATAC-seq) after 24 hr DOX treatment of *OCT4^cond^* ESCs. Normalised read densities for ATAC-seq and OCT4 ChIP-seq are presented, with a heatmap indicating their annotation as either promoters or distal regulatory elements (right). (**G**) A metaplot of *OCT4^cond^* ATAC-seq signal before (UNT) and after 24 hr DOX treatment at OCT4 binding sites with significant reductions in ATAC-seq signal (OCT4-dependent; *n* = 11557) and those without significant changes (OCT4-independent; *n* = 4362). Tn5 control represents transposition of purified genomic DNA to control for potential sequence bias. (**H**) As in (**G**), profiling the changes in nucleosome occupancy before (UNT) and after (DOX) OCT4 depletion. Nucleosome signal was generated using the NucleoATAC package. (**I**) Piecharts identifying the proportion of OCT4-bound distal regulatory elements (left) or OCT4-bound promoters (right) that display significant changes in chromatin accessibility as measured by ATAC-seq. Changes were deemed to be significant with *FDR* \< 0.05 and a fold change greater than 1.5-fold. (**J**) A metaplot depicting the *OCT4^cond^* ATAC-seq signal before (UNT) and after (DOX) treatment at the 25% of OCT4 peaks with the greatest changes in ATAC-seq signal following OCT4 depletion. (**K**) Gene ontology analysis for genes closest to OCT4 target sites depicted in (**J**). This reveals an enrichment for the pluripotency expression network (left) and biological processes associated with developmental gene regulation (right).**DOI:** [http://dx.doi.org/10.7554/eLife.22631.003](10.7554/eLife.22631.003)10.7554/eLife.22631.004Figure 1---figure supplement 1.Annotation and characterisation of OCT4 binding sites in *OCT4^cond^* ESCs.(**A**) Motif enrichment analysis for canonical motif sequences (top) or de novo motif sequences (bottom) reveals high enrichment for OCT4 (POU5F1) and similar motif sequences in the *OCT4^cond^* OCT4 binding sites (*n* = 15920). % reflects the percentage of OCT4 peaks identified to contain each motif sequence. (**B**) Central enrichment analysis performed by CentriMO reveals that canonical and de novo OCT4 motifs are centrally enriched at OCT4 peak intervals. (**C**) A metaplot of H3K4me1 and H3K4me3 at OCT4 binding sites annotated as distal regulatory elements or promoters. (**D**) A violin plot comparing the distance from OCT4 binding sites annotated as distal regulatory elements or promoters to nearest refGene TSS. *p* denotes significance value by Wilcoxon ranked-sign test.**DOI:** [http://dx.doi.org/10.7554/eLife.22631.004](10.7554/eLife.22631.004)10.7554/eLife.22631.005Figure 1---figure supplement 2.Changes in chromatin accessibility at OCT4-bound sites following depletion of OCT4 in ESCs.(**A**) Genomic snapshots of OCT4-dependent chromatin accessibility (ATAC-seq) before (UNT) and after (DOX) OCT4 depletion. Distal OCT4 binding sites are highlighted in grey boxes. (**B**) Genomic snapshot of OCT4-independent chromatin accessibility at OCT4-bound promoter.**DOI:** [http://dx.doi.org/10.7554/eLife.22631.005](10.7554/eLife.22631.005)10.7554/eLife.22631.006Figure 1---figure supplement 3.Chromatin accessibility profiling at OCT4 binding sites in somatic cell lines or tissues.(**A**) A metaplot of ENCODE DNase-seq profiles for eight mouse cell lines or tissues ([@bib82]) at OCT4 targets most dependent upon OCT4 for normal chromatin accessibility (25% most affected in *OCT4^cond^* ESCs; as in [Figure 1J](#fig1){ref-type="fig"}). This reveals that these sites are completely inaccessible in somatic cell lines or tissues which lack OCT4 expression. (**B**) A metaplot analysis of ENCODE DNase-seq data in (**A**) profiled at DNase I hypersensitive sites identified from each cell line/tissue.**DOI:** [http://dx.doi.org/10.7554/eLife.22631.006](10.7554/eLife.22631.006)

During somatic cell reprogramming, exogenous OCT4 is proposed to function as a pioneer transcription factor that can bind to its sequence motifs in inaccessible regions of chromatin. However, it remains unclear whether binding to inaccessible chromatin is also a feature of normal OCT4 binding in mouse ESCs. To address this important question we used the assay for transposase-accessible chromatin with massively parallel sequencing (ATAC-seq) which provides a genome-wide measure of chromatin accessibility ([@bib7]) and examined ATAC-seq signal in wild type and OCT4-depleted cells. Although OCT4-bound sites were highly accessible in wild type cells, when we examined ATAC-seq signal in the OCT4-depleted ESCs, 72% of OCT4 targets showed significant reductions in chromatin accessibility ([Figure 1E,F,G](#fig1){ref-type="fig"} and [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}) and increases in nucleosome occupancy ([Figure 1H](#fig1){ref-type="fig"}). These observations are in agreement with previous studies describing a role for OCT4 in maintaining nucleosome-depleted regions and/or chromatin accessibility at individual loci in pluripotent cells ([@bib81]; [@bib58]) or genome-wide ([@bib13]; [@bib43]). Importantly, OCT4-bound distal regulatory elements appeared to be most significantly affected, while OCT4-bound promoters experienced few significant reductions in accessibility ([Figure 1I](#fig1){ref-type="fig"}). Consistent with a pioneering-like role for OCT4 in shaping chromatin structure, many OCT4-bound regulatory elements were completely inaccessible in the OCT4-depleted ESCs ([Figure 1F,J](#fig1){ref-type="fig"}) and lacked any detectable chromatin accessibility in cells and tissues lacking OCT4 expression ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). Importantly, OCT4 binding sites that displayed reduced accessibility following OCT4 removal were often in close proximity with genes implicated in the pluripotency regulatory network ([Figure 1K](#fig1){ref-type="fig"}), suggesting that these OCT4 binding events may be implicated with the maintenance of pluripotency-associated gene expression. These observations therefore establish that the majority of OCT4 binding events in pluripotent stem cells occur at sites that would otherwise be inaccessible and occupied by nucleosomes, indicating that OCT4 is required to maintain accessible chromatin at its target sites not only during cellular reprogramming but also in the established pluripotent state.

OCT4 supports transcription factor binding at distal regulatory elements to regulate pluripotency-associated genes {#s2-2}
------------------------------------------------------------------------------------------------------------------

A defining feature of pioneer transcription factors is their capacity to support additional transcription factor occupancy, potentially through alteration of local chromatin structure. Given that removal of OCT4 had widespread effects on chromatin accessibility at its binding sites, we wondered whether its absence would result in defects in the binding of other pluripotency-associated transcription factors. To address this possibility, we used ChIP-seq to examine the binding of SOX2 and NANOG in the presence or absence of OCT4 ([Figure 2](#fig2){ref-type="fig"}). Interestingly, we observed major reductions in SOX2 and NANOG binding at the OCT4 target sites that experienced the largest reductions in chromatin accessibility ([Figure 2A,B](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1A,B](#fig2s1){ref-type="fig"}). Importantly, the reductions in SOX2 and NANOG binding correlated extremely well with the reductions in chromatin accessibility at OCT4-bound sites ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). Conversely, the smaller subset of OCT4-bound sites that retained chromatin accessibility following OCT4 depletion retained SOX2 or NANOG occupancy ([Figure 2B](#fig2){ref-type="fig"}). This suggests that OCT4 plays a central role in supporting combinatorial binding and chromatin accessibility at the majority of OCT4 binding sites.10.7554/eLife.22631.007Figure 2.Loss of OCT4 leads to reduced pluripotency-associated transcription factor binding and expression of nearby genes.(**A**) A heatmap illustrating SOX2 and NANOG ChIP-seq at OCT4 targets (*n* = 15920) ranked by their loss of chromatin accessibility (ATAC-seq) after 24 hr DOX treatment of *OCT4^cond^* ESCs, as in [Figure 1F](#fig1){ref-type="fig"}. (**B**) A metaplot of *OCT4^cond^* SOX2 and NANOG ChIP-seq signal before (UNT) and after 24 hr DOX treatment at OCT4 binding sites with significant reductions in ATAC-seq signal (OCT4-dependent; *n* = 11557) and those without significant changes (OCT4-independent; *n* = 4362). (**C**) A heatmap of the log2 fold change in RNA-seq signal of the closest gene to OCT4 target sites depicted in (**A**), following 24 hr DOX treatment of the *OCT4^cond^* ESCs. (**D**) A genomic snapshot of *Utf1*, which is decreased in expression following loss of OCT4. The distal OCT4 target site is highlighted by a grey box. (**E**) Comparison of log2 fold change (log2FC) in RNA-seq signal for genes neighbouring OCT4 target sites that rely on OCT4 for ATAC-seq signal (OCT4-dependent; *n* = 11557) or those that do not (OCT4-independent; *n* = 4362). (**F**) A Venn diagram comparing the OCT4 binding sites for which the nearest gene has significantly reduced expression after OCT4 ablation (orange; *n* = 1979) and the OCT4 targets with significant reductions in chromatin accessibility (red; *n* = 8788). Only OCT4 target sites for which the nearest gene has sufficient RNA-seq coverage are included. (**G**) A violin plot comparing the distance from OCT4 binding sites with OCT4-dependent (*n* = 11557) or OCT4-independent (*n* = 4362) chromatin accessibility to nearest TSS with significant reductions in RNA-seq following 24 hr DOX treatment of the *OCT4^cond^* ESCs (*n* = 1430). (**H**) Gene ontology analysis for genes down-regulated after loss of OCT4 (*n* = 1430) reveals enrichment of the pluripotency transcriptional network.**DOI:** [http://dx.doi.org/10.7554/eLife.22631.007](10.7554/eLife.22631.007)10.7554/eLife.22631.008Figure 2---figure supplement 1.Loss of SOX2 and NANOG is highly correlated with reductions in chromatin accessibility at OCT4-SOX2-NANOG targets.(**A**) A Venn diagram depicting the relationship between significant reductions in ATAC-seq and SOX2/NANOG ChIP-seq signal at OCT4-SOX2-NANOG co-bound peaks (*n* = 5611). % denotes percentage of OCT4-SOX2-NANOG peaks with significant reduction for each factor or assay. (**B**) A violin plot comparing the log2 fold change in SOX2 and NANOG ChIP-seq signal after depletion of OCT4 between OCT4-SOX2-NANOG co-bound peaks with OCT4-dependent (*n* = 3941) or OCT4-independent (*n* = 1644) chromatin accessibility. (**C**) Scatterplots depicting log2 fold changes of SOX2 or NANOG against the log2 fold change in chromatin accessibility (measured by ATAC-seq) at OCT4-SOX2-NANOG co-bound targets (*n* = 5611) in *OCT4^cond^* ESCs after 24 hr DOX treatment.**DOI:** [http://dx.doi.org/10.7554/eLife.22631.008](10.7554/eLife.22631.008)

To understand whether this loss of combinatorial transcription factor binding was relevant to gene regulation, we carried out nuclear RNA-seq in wild type and OCT4-depleted cells. Loss of OCT4-dependent chromatin accessibility and transcription factor binding was broadly associated with the down-regulation of nearby genes ([Figure 2C--E](#fig2){ref-type="fig"}), such as the pluripotency-associated *Utf1* gene ([Figure 2D](#fig2){ref-type="fig"}). When we examined this relationship across the genome, reductions in the expression of genes near OCT4-bound distal sites was highly coincident (82%) with reductions in chromatin accessibility ([Figure 2F](#fig2){ref-type="fig"}). Interestingly, however, reductions in chromatin accessibility at an OCT4-bound site did not always lead to alterations in the expression of neighbouring gene, suggesting that some bound sites may not function in gene regulation or that they may have regulatory capacity that extends beyond the nearest gene. Nevertheless, genes that were down-regulated in OCT4-depleted ESCs (*n* = 1430; OCT4-dependent gene expression) tended to be significantly closer to OCT4 binding sites that displayed reduced chromatin accessibility (median distance 16.2 kb) than OCT4 binding sites that retained chromatin accessibility in the absence of OCT4 (median distance 125.4 kb) ([Figure 2G](#fig2){ref-type="fig"}). These sites were also characterized by reductions in SOX2 and NANOG binding ([Figure 2A,B](#fig2){ref-type="fig"}) and their associated genes were enriched for the pluripotency-associated transcriptional network ([Figure 2H](#fig2){ref-type="fig"}). Together, these observations reveal that OCT4 binding plays a primary and widespread role in shaping combinatorial binding of transcription factors at otherwise inaccessible regulatory sites in ESCs, and this activity underpins pluripotency-associated gene expression.

The chromatin remodelling enzyme BRG1 is enriched at sites where OCT4 is responsible for chromatin accessibility {#s2-3}
----------------------------------------------------------------------------------------------------------------

Several modalities have been proposed to explain how pioneer factors facilitate chromatin accessibility at otherwise inaccessible regions of the genome. For example, pioneer transcription factors may bind their target motifs and evict or exclude nucleosomes through steric mechanisms ([@bib17]; [@bib28]; [@bib72]) or they may exploit the activity of chromatin remodelling enzymes ([@bib46]; [@bib10]; [@bib66]). However, the relative contribution of such mechanisms to pioneer transcription factor function remains poorly understood and unaddressed for OCT4. What is clear from our analysis in ESCs is that the majority of OCT4-bound sites exist in an inaccessible chromatin state in its absence, and that OCT4 plays a primary role in supporting SOX2 and NANOG binding at these sites. To examine whether this pioneering-like activity could potentially rely on the activity of ATP-dependent chromatin remodelling enzymes, we took advantage of the extensive ChIP-seq analysis of chromatin remodelling enzymes that exists for mouse ESCs ([@bib73]; [@bib18]), and simply examined across the complete complement of accessible sites in the mouse ESC genome whether there was a relationship between binding of any these enzymes and the dependency on OCT4 for chromatin accessibility. Remarkably, of the nine individual chromatin remodelling complexes examined, only BRG1 (SMARCA4), a catalytic ATPase subunit of the vertebrate SWI/SNF chromatin remodelling complex (also referred to as BRG1-associated factor (BAF) remodelling complexes), showed an appreciable correlation between occupancy and the reliance on OCT4 for chromatin accessibility ([Figure 3A](#fig3){ref-type="fig"}). Indeed, BRG1 was significantly enriched at regulatory elements that relied on OCT4 for chromatin accessibility (OCT4-dependent ATAC peaks) and regulatory elements bound by OCT4 ([Figure 3B--D](#fig3){ref-type="fig"}). Furthermore, OCT4 and BRG1 occupancy was highly correlated throughout the mouse ESC genome ([Figure 3E](#fig3){ref-type="fig"} and [@bib31], [@bib37], [@bib18]), supporting the possibility that there may be a functional link between OCT4 binding, BRG1, and chromatin accessibility.10.7554/eLife.22631.009Figure 3.The chromatin remodelling enzyme BRG1 is required to create accessible chromatin at OCT4 target sites.(**A**) A Pearson correlation matrix comparing log2 fold change in ATAC-seq signal in OCT4-depleted cells with wild type ESC ChIP-seq signal for nine chromatin remodellers at wild type ATAC hypersensitive peaks (*n* = 76,642). (**B**) A metaplot of BRG1 ChIP-seq signal at ATAC hypersensitive peaks with (OCT4-dependent) or without (OCT4-independent) significant reduction in ATAC-seq signal following removal of OCT4. (**C**) A violin plot quantifying and comparing BRG1 ChIP-seq reads per kilobase per million (RPKM) at OCT4-dependent or OCT4-independent ATAC-seq peaks depicted in (**B**). (**D**) A metaplot of BRG1 ChIP-seq signal at OCT4-bound or OCT4-free ATAC-seq peaks. (**E**) Genome-wide correlation of OCT4, BRG1, H3K4me1 and H3K4me3 in 2 kb windows reveals a high degree of co-localization between OCT4 and BRG1. (**F**) Western blot analysis for the indicated proteins in *Brg1^fl/fl^* mouse ESCs before (UNT) and after 72 hr tamoxifen (TAM) treatment. (**G**) Alkaline phosphatase staining of *Brg1^fl/fl^* ESCs before (UNT) and after 72 hr TAM treatment. (**H**) A genomic snapshot of BRG1 ChIP-seq and ATAC-seq in *Brg1^fl/fl^* ESCs before (UNT) and after 72 hr TAM treatment at the distal OCT4 target site downstream of *Utf1* (highlighted in grey). The *OCT4^cond^* ATAC-seq is included for comparison and reveals a co-dependency on OCT4 and BRG1 for normal chromatin accessibility. (**I**) A heat map of BRG1 ChIP-seq and ATAC-seq at OCT4 target sites (*n* = 15920) in *Brg1^fl/fl^* ESCs before (UNT) and after 72 hr TAM treatment. Sites are ranked by loss of ATAC-seq signal following removal of OCT4, as in [Figure 1F](#fig1){ref-type="fig"}, and the *OCT4^cond^* ATAC-seq is included for comparison. (**J**) As in (**I**), changes in nucleosome occupancy before (UNT) and after (TAM) BRG1 depletion are plotted based on nucleosome signal derived from the NucleoATAC package.**DOI:** [http://dx.doi.org/10.7554/eLife.22631.009](10.7554/eLife.22631.009)10.7554/eLife.22631.010Figure 3---figure supplement 1.OCT4 target sites require BRG1 to maintain chromatin accessibility.(**A**) Genomic snapshots of BRG1 ChIP-seq and ATAC-seq in *Brg1^fl/fl^* ESCs before (UNT) and after 72 hr TAM treatment at two distal OCT4 target sites (highlighted in grey). The *OCT4^cond^* ATAC-seq is included for comparison and reveals dependency on both OCT4 and BRG1 for chromatin accessibility. (**B**) A metaplot of *Brg1^fl/fl^* ATAC-seq signal before (UNT) and after 72 hr TAM treatment at OCT4 binding sites that rely upon OCT4 for chromatin accessibility (OCT4-dependent; *n* = 11557) and those that do not (OCT4-independent; *n* = 4362), as in [Figure 1G](#fig1){ref-type="fig"}. Tn5 control represents transposition of purified genomic DNA to control for potential sequence bias. (**C**) Same as in (**B**), but profiling the changes in nucleosome occupancy before (UNT) and after (TAM) BRG1 depletion. Nucleosome signal was generated using the NucleoATAC package. (**D**) Venn diagram overlap of OCT4 targets which significantly lose ATAC-seq signal (*FDR* \< 0.05; fold change \> 1.5) following deletion of OCT4 (*OCT4^cond^*) or BRG1 (*Brg1^fl/fl^*). (**E**) *K*-means clustering of OCT4 binding sites that significantly lose ATAC-seq signal following deletion of OCT4 (OCT4-dependent; *n* = 11557) based on changes in *Brg1^fl/fl^* ATAC-seq signal. (**F**) Scatterplots of the changes in *OCT4^cond^* and *Brg1^fl/fl^* ATAC-seq at OCT4 target sites. R^2^ represents linear regression score, and *cor* reflects Pearson correlation coefficient.**DOI:** [http://dx.doi.org/10.7554/eLife.22631.010](10.7554/eLife.22631.010)

BRG1 is required to create accessible chromatin at OCT4 target sites in ESCs {#s2-4}
----------------------------------------------------------------------------

BRG1, like OCT4, is essential for maintaining ESC pluripotency ([@bib31]; [@bib37]; [@bib84]), supporting early embryonic development ([@bib9]) and improving the efficiency of iPSC reprogramming ([@bib60]). However, the defined molecular mechanisms by which BRG1 and the BAF complex contribute to maintenance of the pluripotent ESC state remain unclear. Based on our observation that BRG1 was enriched at sites that rely on OCT4 binding for chromatin accessibility ([Figure 3A--C](#fig3){ref-type="fig"}), we reasoned that OCT4 may require BRG1 to shape chromatin accessibility and gene regulatory capacity of OCT4-bound sites in maintaining the pluripotent state. To address this possibility we performed ATAC-seq on a conditional mouse ESC line in which BRG1 expression can be conditionally ablated following addition of tamoxifen (*Brg1^fl/fl^*) ([@bib31]). Tamoxifen treatment resulted in near complete loss of BRG1 by 72 hr, but importantly, BRG1-depleted cells retained normal ESC morphology, were alkaline phosphatase positive, and expressed wild type levels of OCT4, SOX2 and NANOG as described previously ([@bib32]) ([Figure 3F--G](#fig3){ref-type="fig"}). When we examined ATAC-seq signal at several OCT4 target sites in the BRG1-depleted ESCs, we observed substantial reductions in chromatin accessibility compared to the untreated control ESCs, and these effects were similar to the reductions observed in the OCT4-depleted ESCs ([Figure 3H](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). When we extended this analysis to all OCT4-bound sites, it was clear that chromatin accessibility was reduced ([Figure 3I](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}) and nucleosome occupancy increased following BRG1 depletion at the majority of OCT4 target sites ([Figure 3J](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}). We then used a stringent threshold (fold change \>1.5 and *FDR* \< 0.05) to identify sites that experienced significant reductions in chromatin accessibility following BRG1 removal. This revealed that 45% of OCT4-bound sites showed significantly reduced ATAC-seq signal and these sites were also highly dependent on OCT4 for their accessibility ([Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}). However, we suspected that the use of a threshold to identify affected sites might underestimate the extent of BRG1's contribution. Indeed, when we applied an unbiased clustering approach to examine the relationship between removal of OCT4 and BRG1 in shaping accessibility it was clear that the majority (76%) of OCT4-bound sites that rely on OCT4 for their accessibility were also dependent on BRG1 for their accessibility ([Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}). Importantly, the loss of either OCT4 or BRG1 appeared to result in similar, although not identical, reductions in chromatin accessibility across nearly all OCT4 peaks ([Figure 3I](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1F](#fig3s1){ref-type="fig"}), revealing that both of these factors are required to maintain chromatin accessibility at these loci in mouse ESCs. Together, these observations suggest that BRG1 plays a widespread role in shaping chromatin accessibility at OCT4 target sites in ESCs and raises the interesting possibility that the pioneering-like activity of OCT4 may rely on BRG1.

OCT4 establishes chromatin accessibility by recruiting BRG1 to chromatin {#s2-5}
------------------------------------------------------------------------

Our ATAC-seq experiments revealed an essential role for BRG1 in regulating chromatin accessibility at OCT4 target sites in ESCs. One could envisage several possible mechanisms by which BRG1 could cooperate with OCT4 to achieve this. For example, BRG1 could be actively recruited by OCT4 to target sites in order to create accessible chromatin, or it could alternatively function to broadly remodel the genome and in doing so indirectly support access of OCT4 to its target sites. Given that large scale proteomic studies have previously indicated that BRG1 may interact physically with OCT4 ([@bib50]; [@bib70]; [@bib19]), and BRG1 is enriched at OCT4-bound sites throughout the genome ([Figure 3](#fig3){ref-type="fig"}), we favoured the possibility that OCT4 recruits BRG1 and the associated BAF complex to OCT4 target sites in the genome in order to remodel chromatin and promote chromatin accessibility. In fitting with this possibility, OCT4, BRG1 and the additional BAF subunit, SS18, are enriched within the nucleosome-depleted region at OCT4 target sites ([Figure 4A](#fig4){ref-type="fig"}). To address whether OCT4 was responsible for recruiting BRG1 and BAF complexes to the distal regulatory sites it binds, we performed ChIP-seq for BRG1 and SS18 in wild type and OCT4-depleted ESCs. Although BRG1 and SS18 protein levels were unaffected following removal of OCT4 ([Figure 1A](#fig1){ref-type="fig"}), we observed a dramatic reduction in BRG1 and SS18 binding at OCT4 target sites in the absence of OCT4 ([Figure 4B,C](#fig4){ref-type="fig"}). This loss was specific to OCT4-bound regulatory elements as regulatory elements lacking OCT4 were unaffected ([Figure 4D](#fig4){ref-type="fig"}). Together, these observations suggested that OCT4 shapes chromatin accessibility at its target sites through the recruitment of BRG1/BAF complex. Indeed, when we compared reductions in chromatin accessibility with reductions in BRG1 and SS18 at OCT4 binding sites, there was a good correlation between the loss of these factors and loss of ATAC-seq signal in OCT4-depleted ESCs ([Figure 4E](#fig4){ref-type="fig"}). Interestingly, our observation that OCT4 recruits the BRG1/BAF complex to its target sites in ESCs is in agreement with recent observations that BRG1 is recruited to pluripotency-associated enhancers coincident with the formation of accessible chromatin during iPSC reprogramming ([@bib15]). Together these analyses indicate that OCT4 plays a central role in recruiting BRG1-containing BAF complexes to pluripotency-associated gene regulatory elements and that this is important for creating accessible chromatin at these sites.10.7554/eLife.22631.011Figure 4.OCT4 is required for normal BRG1 chromatin occupancy at OCT4-bound regulatory elements.(**A**) A high resolution metaplot illustrating nucleosome occupancy, OCT4, BRG1 and BRG1-associated factor SS18 at OCT4 peaks (n = 15920; 10 bp windows) demonstrates that OCT4 and BRG1/BAF signal co-localises to the nucleosome-depleted region at OCT4 peaks. (**B**) Genomic snapshots of BRG1 and SS18 ChIP-seq in *OCT4^cond^* before (UNT) and after 24 hr doxycycline (DOX) treatment reveals loss of BRG1 and SS18 occupancy at distal OCT4 targets (highlighted in grey) following OCT4 removal. (**C**) A heatmap of OCT4 peaks (*n* = 15920) illustrating enrichment of BRG1 and SS18 at OCT4 target sites in wild type cells and subsequent loss of BRG1 following removal of OCT4. (**D**) A metaplot of BRG1 and SS18 ChIP-seq signal at ATAC hypersensitive sites with (OCT4-bound) or without (OCT4-free) OCT4 before and after deletion of OCT4. (**E**) A scatterplot comparing the changes in BRG1 and SS18 occupancy with the changes in chromatin accessibility (ATAC-seq) at OCT4 peaks after deletion of OCT4. R^2^ represents linear regression score, and *cor* reflects Pearson correlation coefficient.**DOI:** [http://dx.doi.org/10.7554/eLife.22631.011](10.7554/eLife.22631.011)

BRG1 supports transcription factor binding at distal gene regulatory elements {#s2-6}
-----------------------------------------------------------------------------

We have identified a widespread and important role for the chromatin remodeller BRG1 in creating accessibility at gene regulatory elements bound by OCT4 in ESCs. Given that OCT4 recruits BRG1 to shape chromatin accessibility ([Figure 4](#fig4){ref-type="fig"}), we wondered whether BRG1 was also important to sustain the engagement and function of OCT4, its binding partner SOX2 and the additional pluripotency associated transcription factor NANOG. To examine this interesting possibility, we carried out ChIP-seq for OCT4, SOX2 and NANOG in the BRG1 conditional cells before and after tamoxifen treatment ([Figure 5](#fig5){ref-type="fig"}). Importantly, wild type OCT4 ChIP-seq signal was highly similar in both *Brg1^fl/fl^* ESCs and *OCT4^cond^* ESCs ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). This allowed us to examine the contribution of BRG1 to transcription factor occupancy at *bona fide* OCT4 binding sites ([Figure 1](#fig1){ref-type="fig"}), focusing on OCT4-bound distal regulatory elements as these were the sites most dependent on OCT4 and BRG1 for normal chromatin accessibility. Strikingly, we observed significant reductions in OCT4 binding at the majority (60%; *FDR* \< 0.05 and fold change \>1.5 fold) of distal OCT4 targets following BRG1 removal ([Figure 5A--C](#fig5){ref-type="fig"}), indicating that BRG1 contributes not only to creating accessibility at OCT4 target sites but is also required to sustain normal OCT4 binding in mouse ESCs. Similarly, SOX2 and NANOG binding was also significantly reduced following BRG1 removal in ESCs, although the total number of sites significantly affected was less than for OCT4 (16.7% and 22.9% of distal OCT4 target sites; *FDR* \< 0.05 and fold change \>1.5 fold) ([Figure 5A--C](#fig5){ref-type="fig"}). Importantly, even when we examined the most extremely affected OCT4 target sites (BRG1-dependent), loss of BRG1 did not result in complete loss of transcription factor binding ([Figure 5D](#fig5){ref-type="fig"}), yet resulted in an inability of the cells to maintain the nucleosome-depleted state ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). This suggests that OCT4, SOX2 and NANOG may still be able to recognise their sequence motifs, but are unable to engage in normal and robust binding without the cooperation of BRG1/BAF remodelling complexes. Ultimately, this is consistent with a pioneering activity of OCT4 being required to initially sample and engage with inaccessible chromatin, potentially through the recognition of partial DNA motifs ([@bib62]). However, OCT4-dependent BRG1/BAF recruitment appears to subsequently be required to functionally mature these previously inaccessible sites such that they can now effectively support robust binding of OCT4 and additional pluripotency-associated transcription factors.10.7554/eLife.22631.012Figure 5.BRG1 supports pluripotency-associated transcription factor binding to functionally mature distal gene regulatory elements.(**A**) Genomic snapshots illustrating OCT4, SOX2 and NANOG ChIP-seq signal in *Brg1^fl/fl^* ESCs before (UNT) and after tamoxifen (TAM) treatment for 72 hr. Three examples of distal OCT4 targets are depicted, with affected sites highlighted in grey. (**B**) A heatmap analysis of OCT4, SOX2 and NANOG ChIP-seq signal at distal OCT4 targets (*n* = 11967) ranked by their relative change in OCT4 ChIP-seq after deletion of BRG1. (**C**) Piecharts depicting the significant changes in OCT4, SOX2 and NANOG ChIP-seq signal at distal OCT4 target sites, identified using the DiffBind package. Changes were deemed significant with *FDR* \< 0.05 and a change greater than 1.5-fold. (**D**) Metaplot analysis of OCT4, SOX2 and NANOG binding at distal OCT4 target sites that are the most (20% most affected; BRG1-dependent) and the least (20% least affected; BRG1-independent) dependent on BRG1 for normal OCT4 binding. (**E**) A heatmap illustrating the changes in gene expression (log2 fold change in RNA-seq) for genes neighbouring distal OCT4 targets. Genes are sorted according to the change in OCT4 occupancy at neighbouring distal OCT4 target sites following BRG1 removal, as in (**B**). Gene expression changes for OCT4-depleted (*OCT4^cond^*) or BRG1-depleted (*Brg1^fl/fl^*) ESCs relative to wildtype ESCs are shown. (**F**) Quantitation of log2 fold change (log2FC) in *Brg1^fl/fl^* RNA-seq signal for genes neighbouring distal OCT4 target sites grouped into quintiles based on the change in OCT4 binding at neighbouring distal OCT4 target sites following removal of BRG1, as in (**B**). (**G**) Comparison of significant gene expression changes for genes neighbouring distal OCT4 target sites that show the largest (20% most affected; BRG1-dependent) and least (20% least affected; BRG1-independent) reductions in OCT4 ChIP-seq signal following BRG1 removal. Changes were deemed significant with *FDR* \< 0.05 and a change greater than 1.5-fold, using DESeq2. (**H**) Quantitation of log2 fold change (log2FC) of OCT4, SOX2 and NANOG ChIP-seq signal at distal OCT4 targets in proximity to OCT4-dependent genes with decreased (↓; *n* = 468), unchanged (-; *n* = 639), or increased (↑; *n* = 816) RNA-seq signal after deletion of BRG1 (as identified in [Figure 5---figure supplement 3B](#fig5s3){ref-type="fig"}).**DOI:** [http://dx.doi.org/10.7554/eLife.22631.012](10.7554/eLife.22631.012)10.7554/eLife.22631.013Figure 5---figure supplement 1.Comparison of wild type OCT4 ChIP-seq signal between *OCT4^cond^* and *Brg1^fl/fl^* ESCs.Scatterplot analysis of reads per kilobase per million (RPKM) for untreated (wild type) OCT4 ChIP-seq in *OCT4^cond^* and *Brg1^fl/fl^* ESCs.**DOI:** [http://dx.doi.org/10.7554/eLife.22631.013](10.7554/eLife.22631.013)10.7554/eLife.22631.014Figure 5---figure supplement 2.Nucleosome occupancy changes in *Brg1^fl/fl^* ESCs at distal OCT4 target sites.Metaplot analysis of nucleosome occupancy signal at distal OCT4 target sites that are the most (20% most affected; BRG1-dependent) and the least (20% least affected; BRG1-independent) dependent on BRG1 for OCT4 binding (as in [Figure 5D](#fig5){ref-type="fig"}).**DOI:** [http://dx.doi.org/10.7554/eLife.22631.014](10.7554/eLife.22631.014)10.7554/eLife.22631.015Figure 5---figure supplement 3.Transcriptional regulation of OCT4-dependent target genes by BRG1.(**A**) Venn diagrams depicting the overlap between genes with significant reductions in RNA-seq following OCT4-depletion in the *OCT4^cond^* ESCs (OCT4-dependent) and genes with significant decreases or increases in RNA-seq following BRG1-depletion in the *Brg1^fl/fl^* ESCs. DESeq2 was used to identify significant changes (*FDR* \< 0.05 and fold change \> 1.5 fold). (**B**) *K*-means clustering of OCT4-dependent genes based on changes in *Brg1^fl/fl^* RNA-seq signal. Clusters were organized into three groups to reflect the direction of gene expression change following removal of BRG1. (**C**) Boxplot quantitation of log2 fold change in *Brg1^fl/fl^* RNA-seq signal following removal of BRG1 for the three groups of OCT4-dependent genes identified in (**B**) illustrates the utility of the clustering approach.**DOI:** [http://dx.doi.org/10.7554/eLife.22631.015](10.7554/eLife.22631.015)10.7554/eLife.22631.016Figure 5---figure supplement 4.Changes in gene expression following depletion of BRG1 in *Brg1^fl/fl^* ESCs are associated with altered transcription factor binding.Genomic snapshots of three genes associated with OCT4 binding sites that experience either decreased (*Fgf4*), unchanged (*Utf1)* or increased (*Ankle2)* RNA-seq signal following depletion of BRG1 in *Brg1^fl/fl^* ESCs. OCT4 binding sites are highlighted in grey.**DOI:** [http://dx.doi.org/10.7554/eLife.22631.016](10.7554/eLife.22631.016)

Gene expression defects in the absence of BRG1 are linked to altered transcription factor binding {#s2-7}
-------------------------------------------------------------------------------------------------

In the absence of BRG1, the stable binding of pluripotency transcription factors OCT4, SOX2 and NANOG was disrupted at distal regulatory elements, suggesting that this may affect expression of the pluripotency-associated transcriptional network. Somewhat surprisingly, previous work has not supported a clear correlation between loss of BRG1 and reduced activity of OCT4 target genes ([@bib31], [@bib32]; [@bib84]; [@bib27]), despite our observations that BRG1 plays an important role in transcription factor binding at many distal regulatory elements in close proximity to pluripotency-associated genes. However, we also observed that the effect on OCT4, SOX2 and NANOG binding following BRG1 removal varied in magnitude between individual sites, with some sites actually displaying increases in transcription factor binding ([Figure 5A--D](#fig5){ref-type="fig"}). We therefore reasoned that transcriptional effects following loss of BRG1 might not precisely correlate with the expression changes following OCT4 removal but may instead be related to alterations in OCT4, SOX2 and NANOG binding at individual regulatory sites.

To examine this possibility, we carried out nuclear RNA-seq in wild type and BRG1-depleted cells, and compared gene expression changes to those observed following conditional removal of OCT4 ([Figure 5E](#fig5){ref-type="fig"} and [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}). As described earlier ([Figure 2](#fig2){ref-type="fig"}), genes in close proximity to OCT4 binding sites tended to be down-regulated following loss of OCT4 ([Figure 5E](#fig5){ref-type="fig"}). When we simply overlapped the genes that showed significant reductions in gene expression following OCT4 removal (OCT4-dependent genes; *FDR* \< 0.05 and fold change \>1.5) with genes that significantly changed in expression following BRG1 removal, the overlap was low ([Figure 5---figure supplement 3A](#fig5s3){ref-type="fig"}). This was in agreement with previous work that did not identify a clear correlation between gene expression changes following OCT4 and BRG1 removal ([@bib31], [@bib32]; [@bib84]; [@bib27]). However, when we examined this relationship in more detail using unbiased clustering of the OCT4-dependent genes based on their expression changes after removal of BRG1, we identified three separate types of response; genes that showed reduced expression (28.1%), genes whose expression was unchanged (35.2%), and genes that had increased gene expression (36.7%) ([Figure 5---figure supplement 3B,C](#fig5s3){ref-type="fig"}). Given that individual distal regulatory elements vary in their requirement for BRG1 in OCT4, SOX2 and NANOG binding ([Figure 5A--D](#fig5){ref-type="fig"}), we examined whether these changes in gene expression corresponded to changes in transcription factor binding at nearby distal regulatory elements. Importantly, this analysis revealed that the expression of genes associated with sites that rely on BRG1 for OCT4 binding tended to be reduced following deletion of BRG1 ([Figure 5E--G](#fig5){ref-type="fig"}, [Figure 5---figure supplement 4](#fig5s4){ref-type="fig"}). In contrast, genes associated with unchanged or increased OCT4, SOX2 and NANOG binding tended to show increases in expression ([Figure 5E--G](#fig5){ref-type="fig"}, [Figure 5---figure supplement 4](#fig5s4){ref-type="fig"}). Furthermore, distal OCT4 binding sites in close proximity to OCT4/BRG1 dependent genes experienced the largest reductions in transcription factor binding following removal of BRG1 ([Figure 5H](#fig5){ref-type="fig"}). Therefore, our new genome-wide analysis suggests that altered transcription factor binding is a major determinant of the gene expression changes in BRG1-depleted ESCs, with the direction and magnitude of expression change being dictated by effects on transcription factor binding at nearby distal regulatory elements. Importantly, these observations support a model where BRG1 is required to stabilize and mature pioneer binding events by OCT4 at inaccessible distal regulatory elements and to transition these sites into functionally active regulatory elements that control the transcription of nearby genes. In contrast, some distal regulatory elements rely less on BRG1 for transcription factor binding and exhibit less pronounced reductions, or even increases, in the expression of their associated genes. Together our new analyses explain why previous studies had failed to identify a simple relationship between gene expression changes following OCT4 and BRG1 removal and demonstrate that reduced expression of a subset of OCT4 target genes results from the inability of OCT4 and other transcription factors to bind their target sites following BRG1 removal.

BRG1-dependency reveals distinct modes of OCT4 function at distal regulatory elements during reprogramming and development {#s2-8}
--------------------------------------------------------------------------------------------------------------------------

Through studying OCT4 function in iPSC reprogramming it has been proposed that there may be distinct phases of OCT4 binding which are influenced by pre-existing chromatin states in somatic cells ([@bib61]; [@bib8]; [@bib11]). For example, OCT4 occupies a subset of sites during the early stages of reprogramming which are modified by histone H3 lysine 4 dimethylation or histone H3 lysine 27 acetylation and associated with more accessible chromatin. This is followed by OCT4 binding at sites lacking pre-existing chromatin modifications that are thought to become accessible during the later stages of reprogramming when pluripotency is established. This suggests that OCT4 binding may occur via different mechanisms to support regulatory element function during reprogramming and development.

In light of our observation in ESCs that some OCT4 binding does not require BRG1, we wanted to examine whether the requirement for BRG1 at these sites reflected the dynamics of gene expression during cellular reprogramming and early development. We therefore analysed gene expression during the reprogramming of mouse fibroblasts into iPSCs via OCT4/SOX2/KLF4/MYC from two independent studies ([@bib11]; [@bib16]). Specifically, we examined genes that required OCT4 for their expression in ESCs (OCT4-dependent) and separated these into genes associated with BRG1-independent or BRG1-dependent OCT4 binding at neighbouring distal regulatory elements in ESCs (see [Figure 5](#fig5){ref-type="fig"}). We then compared the timing of their expression during the iPSC reprogramming process. This revealed that genes associated with BRG1-independent OCT4 binding were activated early during reprogramming and BRG1-dependent sites later ([Figure 6A](#fig6){ref-type="fig"}). This suggests that OCT4 expression in somatic cells leads to a more immediate transcriptional response from genes associated with BRG1-independent OCT4 binding, presumably due to pre-existing chromatin accessibility at these loci ([@bib11]). In contrast, genes that require BRG1 for OCT4 binding were expressed later during reprogramming, perhaps because OCT4 requires BRG1 at these sites to remodel chromatin and mature the function of these regulatory elements. In fitting with this possibility, BRG1-dependent OCT4 binding sites were also associated with genes expressed at later developmental stages during early mouse development ([Figure 6B](#fig6){ref-type="fig"}), suggesting that chromatin state in the early embryo may also shape how these OCT4 target sites are used during development. To explore this possibility, we examined the activation of BRG1-independent and BRG1-dependent OCT4 targets in the early mouse embryo using chromatin accessibility as a proxy for OCT4 binding and regulatory activity ([@bib43]; [@bib76]). Interestingly, this demonstrated that BRG1-dependent OCT4 target sites became accessible at later stages of embryonic development ([Figure 6C](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). This suggests that developmental transitions may require both OCT4-dependent chromatin binding and BRG1-dependent remodelling activities to overcome the activation barrier set by chromatin. In contrast, the pre-existing chromatin state at a subset of OCT4 target sites (BRG1-independent) may allow them to be activated more rapidly. Importantly, these observations suggest that chromatin structure likely plays an important role in regulating how OCT4 engages with and functions in the genome not only in mouse ESCs but also during reprogramming and development.10.7554/eLife.22631.017Figure 6.BRG1-dependency reveals distinct modes of OCT4 function of distal regulatory elements during reprogramming and development.(**A**) A time course of gene expression changes (log2 fold change) during OKSM-mediated reprogramming of mouse embryonic fibroblasts to iPSCs ([@bib11]; [@bib16]). The expression changes of OCT4-dependent genes neighbouring the 20% of distal OCT4 targets that were most dependent upon BRG1 for normal OCT4 binding (BRG1-dependent) or the 20% of distal OCT4 targets that were least dependent (BRG1-independent) following BRG1 removal were quantified and visualised as a smoothed trendline ±95% confidence interval. (**B**) Genomic Regions Enrichment of Annotations Tool (GREAT) annotation of BRG1-dependent and BRG1-independent distal OCT4 targets. Plotted are the enrichment (-log10(P Value)) against the MGI Expression profile, or Thieler development stage, for genes neighbouring distal OCT4 targets. BRG1-independent sites are strongly enriched for gene expression profiles consistent with very early embryonic stages. (**C**) Metaplot profiles of ATAC-seq signal during early mouse embryonic development ([@bib76]) at BRG1-independent (upper) and BRG1-dependent (lower) distal OCT4 target sites. BRG1-independent sites gain accessibility earlier than BRG1-dependent sites. (**D**) A quantitation of ATAC-seq read density at distal OCT4 targets depicted in (**C**) during early embryonic development plotted as a smoothed trendline ±95% confidence interval.**DOI:** [http://dx.doi.org/10.7554/eLife.22631.017](10.7554/eLife.22631.017)10.7554/eLife.22631.018Figure 6---figure supplement 1.BRG1-dependent and BRG1-independent OCT4 binding at distal regulatory elements is associated with distinct developmental timing of chromatin accessibility.(**A**) Metaplot profiles of DNase-seq signal during early embryonic development ([@bib43])at BRG1-independent and BRG1-dependent distal OCT4 targets identified in Brg1^fl/fl^ ESCs. BRG1-independent sites gain accessibility earlier than BRG1-dependent sites. (**B**) A quantitation of DNase-seq read density at distal OCT4 targets depicted in (**A**) during early embryonic development depicted as a smoothed trendline ± 95% confidence interval.**DOI:** [http://dx.doi.org/10.7554/eLife.22631.018](10.7554/eLife.22631.018)

Discussion {#s3}
==========

Although the capacity of pioneer transcription factors to bind their sequence motifs in chromatinized DNA has been studied in detail, the mechanisms that support how individual pioneer transcription factors function to create accessible chromatin and shape regulatory element function remain poorly defined. Through studying the pioneer transcription factor OCT4, we establish that OCT4 binds to sites in mouse ESCs that would otherwise be inaccessible to shape chromatin accessibility and transcription factor binding ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). This suggests that the pioneering activities of OCT4 are required not only during reprogramming, but also in the established pluripotent state. Interestingly, chromatin accessibility formed at OCT4 binding sites relies on the chromatin remodelling factor BRG1 ([Figure 3](#fig3){ref-type="fig"}) which is recruited to these sites by OCT4 ([Figure 4](#fig4){ref-type="fig"}). The occupancy of BRG1 is then required to support efficient OCT4, SOX2 and NANOG binding and normal expression of the pluripotency-associated transcriptome ([Figure 5](#fig5){ref-type="fig"}). Importantly, this reliance on BRG1 reflects OCT4 binding dynamics during cellular reprogramming and early mouse development ([Figure 6](#fig6){ref-type="fig"}). Together these observations reveal a distinct requirement for the chromatin remodelling factor BRG1 in shaping the activity of the pioneer transcription factor OCT4 and regulating the pluripotency network in embryonic stem cells.

Pioneer transcription factors play very defined roles in shaping gene expression in response to cellular reprogramming ([@bib61]; [@bib53]; [@bib5]; [@bib11]), developmental stimuli, and environmental cues ([@bib34]; [@bib77]; [@bib3]; [@bib57]). While considerable effort has focused on characterizing the chromatin binding activity of pioneer transcription factors, both in vitro and in vivo, the mechanisms by which individual pioneer transcription factors shape chromatin structure and support further transcription factor engagement in vivo have remained poorly understood. Our examination of OCT4 binding now provides a potential rationalization for how this pioneer transcription factor functions to form gene regulatory elements in mouse ESCs. A requirement of this process is OCT4\'s ability to engage with sequences in inaccessible chromatin presumably through its capacity to bind nucleosomal DNA ([Figure 1](#fig1){ref-type="fig"}; [@bib61], [@bib62]), suggesting that OCT4 may be able to dynamically sample its target sites throughout the genome. However, cooperation with BRG1 appears to be required for more stable OCT4 binding ([Figure 5](#fig5){ref-type="fig"}). This could be achieved through the chromatin remodelling activity of BRG1 creating transiently accessible DNA that facilitates further OCT4 binding and ultimately more stable cooperative binding with other transcription factors like SOX2 and NANOG. This general model is consistent with previous experiments that showed enhanced OCT4 binding during OCT4-SOX2-KLF4 reprogramming when BRG1 was included in the reprogramming cocktail ([@bib60]) and is in agreement with our observation that BRG1 is required for normal chromatin accessibility and OCT4 binding at otherwise inaccessible and inactive regulatory elements.

The capacity of OCT4 to recognise its target motifs in inaccessible chromatin may allow it to dynamically sample its complement of binding sites in the genome. However, like many transcription factors, OCT4 only binds stably to a subset of these sites. Our genome-wide analyses indicate that BRG1 and transcription factor co-binding events appear to be essential in stabilizing OCT4 binding and the functional maturation of OCT4-dependent regulatory elements in ESCs. Based on these observations, one would predict that co-binding transcription factors might play a central role in shaping where OCT4 stably engages with the genome in different cell types. In fitting with this possibility, when ESCs are transitioned into epiblast-like cells (EpiLCs), OCT4 stably associates with a new set of previously inaccessible sites in a manner that appears to rely on co-binding of the EpiLC-specific transcription factor OTX2 ([@bib6]; [@bib80]). In the context of these and other observations, it is tempting to speculate that OCT4, through its association with BRG1, is exploited as a dynamic pioneering and chromatin remodelling module by distinct co-binding transcription factors to support the formation of cell type-specific regulatory elements during developmental transitions and reprogramming. In agreement with these general ideas, OCT4 appears to be the only Yamanaka transcription factor that cannot be substituted for in iPSC reprogramming experiments, suggesting its pioneering activity is fundamental in establishing and maintaining the pluripotency network in concert with SOX2, KLF4 and c-Myc ([@bib48]; [@bib65]), perhaps due to its cooperation with BRG1 ([@bib60]; [@bib21]). This central requirement in reprogramming is also consistent with our observations that OCT4 plays an essential and BRG1-dependent role in shaping the binding of other pluripotency-associated factors at thousands of distal regulatory elements in ESCs.

One of the central features of pioneer transcription factors is their ability to alter local chromatin structure, and this is closely linked to their capacity to support further transcription factor binding and enable the functional maturation of distal regulatory elements. Yet, in most instances the defined molecular mechanisms that support these activities have remained undetermined. While some pioneer factors, such as FoxA1, can stably bind their target sites and directly alter nucleosomal structure through steric disruption of histone:DNA contacts ([@bib17]; [@bib28]; [@bib35]), the extent to which other pioneer factors might exploit such a mechanism has yet to be fully addressed. In the case of OCT4, our observations establish that its capacity to support transcription factor binding and chromatin accessibility requires the chromatin remodeller BRG1. This suggests that unlike FoxA1, OCT4 does not have an intrinsic chromatin opening activity, but requires cooperation with BRG1 to achieve this. Indeed, our work on OCT4 is generally consistent with and supported by recent work studying the pioneer factor GATA3 which appears to have similar dependency on BRG1 in creating accessible chromatin ([@bib68]). Furthermore, chromatin remodelling activity has been widely implicated in shaping nucleosome positioning and chromatin accessibility at target sites bound by other pioneer transcription factors ([@bib34]; [@bib55]; [@bib10]; [@bib26]). Together, these observations suggest that many pioneer transcription factors may rely on chromatin remodelling as a key step in supporting transcription factor binding and/or co-binding events in a manner broadly consistent with the previously proposed assisted loading model for transcription factor binding ([@bib72]; [@bib66]). In the context of this model, the dynamic binding, release and re-binding of transcription factors would help to maintain and stabilise transcription factor binding events, but critically, chromatin remodellers appear to be important in many cases to achieve this (reviewed recently in [@bib66]). Clearly more work is required to understand the extent to which pioneer transcription factors use chromatin remodellers to support their pioneering activities. However, in the case of the developmental pioneer transcription factors OCT4 and GATA3, chromatin remodellers act as key component necessary for the formation and function of gene regulatory elements. These emerging observations suggest that chromatin remodelling could function as a central feature of pioneer transcription factor activity during the formation and maintenance of cell type-specific transcriptional programs during development and reprogramming.

Materials and methods {#s4}
=====================

Cell culture and lines {#s4-1}
----------------------

Mouse embryonic stem cell (ESCs) containing a doxycycline-sensitive OCT4 transgene (ZHBTC4; referred to here as *OCT4^cond^* \[[@bib49]\]) were grown on gelatin-coated plates in DMEM (Gibco, Carlsbad, CA) supplemented with 15% FBS, 10 ng/mL leukemia-inhibitory factor, penicillin/streptomycin, beta-mercaptoethanol, L-glutamine and non-essential amino-acids. *OCT4^cond^* cells were treated with 1 µg/mL doxycycline for 24 hr to ablate OCT4 expression, which was verified by Western blotting. *Brg1^fl/fl^* ESCs were previously described ([@bib32]) and maintained in DMEM KnockOut supplemented with 10% FBS and 5% KnockOut Serum Replacement (Life Technologies, Carlsbad, CA), plus additional factors described for *OCT4^cond^* ESCs above. *Brg1^fl/fl^* ESCs were treated with 4-hydroxytamoxifen for 72 hr to ablate BRG1 protein levels, which was verified by Western blotting. Cell lines were routinely tested and confirmed to be mycoplasma-free. Alkaline phosphatase staining was performed by incubating cells with freshly prepared AP buffer (0.4 mg/mL naphthol phosphate N-5000 (Sigma, St Louis, MO), 1 mg/mL Fast Violet B Salt F-161 (Sigma), 100 mM Tris-HCl (pH 9.0), 100 mM NaCl, 5 mM MgCl~2~).

ATAC-seq sample preparation and sequencing {#s4-2}
------------------------------------------

Chromatin accessibility was assayed using an adaptation of the assay for transposase accessible-chromatin (ATAC)-seq ([@bib7]). Briefly, 5 × 10^6^ cells were harvested, washed with PBS and nuclei were isolated in 1 mL HS Lysis buffer (50 mM KCl, 10 mM MgSO~4~.7H~2~0, 5 mM HEPES, 0.05% NP40 \[IGEPAL CA630\]), 1 mM PMSF, 3 mM DTT) for 1 min at room temperature. Nuclei were centrifuged at 1000×*g* for 5 min at 4°C, followed by a total of three washes with ice-cold RSB buffer (10 mM NaCl, 10 mM Tris (pH 7.4), 3 mM MgCl~2~), to remove as much cytoplasmic and mitochondrial material as possible. Nuclei were then counted, and 5 × 10^4^ nuclei were resuspended in Tn5 reaction buffer (10 mM TAPS, 5 mM MgCl~2~, 10% dimethylformamide) and 2 µl of Tn5 transposase (25 µM) made in house according to the previously described protocol ([@bib51]). Nuclei were then incubated for 30 min at 37°C, before isolation and purification of tagmented DNA using QiaQuick MinElute columns (Qiagen, Germany). To control for sequence bias of the Tn5 transposase, a Tn5 digestion control was performed by tagmenting ESC genomic DNA with Tn5 for 30 min at 55°C. ATAC-seq libraries were prepared by PCR amplification using custom made Illumina barcodes previously described ([@bib7]) and the NEBNext High-Fidelity 2X PCR Master Mix (NEB, Ipswich, MA) with 8--10 cycles. Libraries were purified with two rounds of Agencourt AMPure XP bead cleanup (1.5X beads:sample; Beckman Coulter, Brea, CA), followed by quantification by qPCR using SensiMix SYBR (Bioline, UK) and KAPA Library Quantification DNA standards (KAPA Biosystems, Wilmington, MA). ATAC-seq libraries were sequenced on Illumina NextSeq500 using 80 bp paired-end reads in biological triplicate.

Chromatin immunoprecipitation and ChIP-seq library preparation {#s4-3}
--------------------------------------------------------------

Chromatin immunoprecipitation (ChIP) was performed as described previously ([@bib22]), with minor modifications. Cells were fixed for 1 hr in 2 mM DSG and 12.5 min in 1% formaldehyde. Reactions were quenched by the addition of glycine to a final concentration of 125 µM. After cell lysis and chromatin extraction, chromatin was sonicated using a BioRuptor sonicator (Diagenode, Belgium), followed by centrifugation at 16,000×*g* for 20 min at 4°C, and used fresh or stored at −80°C. Chromatin was quantified by denaturing chromatin 1:10 in 0.1M NaOH and measuring DNA concentration by NanoDrop. 150 µg chromatin/IP was diluted ten-fold in ChIP dilution buffer (1% Triton-X100, 1 mM EDTA, 20 mM Tris-HCl (pH 8), 150 mM NaCl) prior to pre-clearing with prepared protein A magnetic Dynabeads (Invitrogen, Carlsbad, CA) which had been blocked for 1 hr with 0.2 mg/mL BSA and 50 µg/mL yeast tRNA. Chromatin samples were then incubated overnight with relevant antibodies at 4°C with rotation. Antibodies used for ChIP experiments were anti-OCT4A (Cell Signaling Technology (CST, Danvers, MA), \#5677), anti-SOX2 (CST, \#23064), anti-Nanog (CST, \#8822), anti-SS18 (CST, \#21792) and anti-BRG1 (abcam (UK), ab110641). Antibody-bound chromatin was isolated on protein A magnetic Dynabeads. ChIP washes were performed with low salt buffer (0.1% SDS, 1% Triton, 2 mM EDTA, 20 mM Tris-HCl (pH 8.1), 150 mM NaCl), high salt buffer (0.1% SDS, 1% Triton, 2 mM EDTA, 20 mM Tris-HCl (pH 8.1), 500 mM NaCl), LiCl buffer (0.25M LiCl, 1% NP40, 1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris-HCl (pH 8.1)) and TE buffer (x2 washes) (10 mM Tris-HCl (pH 8.0), 1 mM EDTA). To prepare ChIP-seq material, ChIP DNA was eluted using 1% SDS and 100 mM NaHCO~3~, and cross-links reversed at 65°C in the presence of 200 mM NaCl. Samples were then treated with RNase and proteinase K before being purified with ChIP DNA Clean and Concentrator kit (Zymo, Irvine, CA). ChIP-seq libraries were prepared using the NEBNext Ultra DNA Library Prep Kit with NEBNext Dual Indices, and sequenced as 38 bp paired-end reads on Illumina NextSeq500 platform. All ChIP-seq experiments were carried out in biological triplicate.

Nuclear RNA-seq sample generation and sequencing {#s4-4}
------------------------------------------------

To isolate nuclear RNA, cells were subjected to nuclei isolation described for ATAC-seq. Nuclei were then resuspended in TriZOL reagent (ThermoScientific, Waltham, MA) and RNA was extracted according to the manufacturer's protocol. Nuclear RNA was treated with the TURBO DNA-free Kit (ThermoScientific) and depleted for rRNA using the NEBNext rRNA Depletion kit and protocol (NEB). RNA-seq libraries were prepared using the NEBNext Ultra Directional RNA-seq kit (NEB) and libraries were sequenced on the Illumina NextSeq500 with 80 bp paired-end reads in biological triplicate.

Massively parallel sequencing, data processing and normalisation {#s4-5}
----------------------------------------------------------------

For ATAC-seq and ChIP-seq, paired-end reads were aligned to the mouse mm10 genome using bowtie2 ([@bib40]) with the '\--no-mixed' and '\--no-discordant' options. Non-uniquely mapping reads and reads mapping to a custom 'blacklist' of artificially high regions of the genome were discarded. For RNA-seq, reads were initially aligned using bowtie2 against the rRNA genomic sequence (GenBank: BK000964.3) to filter out rRNA fragments, prior to alignment against the mm10 genome using the STAR RNA-seq aligner ([@bib20]). To improve mapping of nascent, intronic sequences, reads which failed to map using STAR were aligned against the genome using bowtie2. PCR duplicates were removed using SAMtools ([@bib41]). Biological replicates were randomly downsampled to contain the same number of reads for each individual replicate, and merged to create a representative genome track using DANPOS2 ([@bib12]) which was visualised using the UCSC Genome Browser. Peakcalling analyses were performed using the DANPOS2 dpeak function on untreated and treated samples in biological triplicate with matched input. Merged ATAC-seq datasets were used to extract signal corresponding to nucleosome occupancy information with NucleoATAC ([@bib56]) using a cross correlation model for all regulatory elements (ATAC hypersensitive sites) in each cell line.

Differential binding and gene expression analysis {#s4-6}
-------------------------------------------------

Significant changes in ATAC-seq or ChIP-seq datasets were identified using the DiffBind package ([@bib64]), while for RNA-seq DESeq2 was used with a custom-built, non-redundant mm10 gene set ([@bib42]). Briefly, mm10 refGene genes were filtered on size (\>200 bp), gene body and TSS mappability, unique TSS and TTS, in order to remove poorly mappable and highly similar transcripts. For both DiffBind and DESeq2, a *FDR* \< 0.05 and a fold change \>1.5 fold was deemed to be a significant change. For distal OCT4 intervals, gene expression changes for the nearest TSS were considered. *K*-means clustering to identify OCT4 and BRG1 co-dependency of chromatin accessibility or gene expression was performed using the kmeans function in R. Clusters with similar trends (i.e. decrease, no change, or increase) were then grouped together for subsequent analysis. Changes in ATAC-seq or ChIP-seq were visualised using heatmaps or metaplots produced using HOMER2 ([@bib30]), with heatmaps made using Java TreeView ([@bib54]). Log2 fold change values were visualised using R (v 3.2.1), with scatterplots coloured by density using stat_density2d. Regression and correlation analyses were also performed in R using standard linear models and Pearson correlation respectively. Log2 fold change or reads per kilobase per million (RPKM) values were compared between different classes of transcription factor binding sites either by visualising *gam* smoothed trendlines with 95% confidence intervals or using the Wilcoxon signed-rank test.

Functional annotation of transcription factor binding sites {#s4-7}
-----------------------------------------------------------

OCT4 peaks were identified in the *OCT4^cond^* biological triplicate OCT4 ChIP-seq data using the DANPOS2 dpeak function and only peaks with decreased OCT4 ChIP-seq signal were taken for further analysis (*n* = 15920). OCT4 motif enrichment analysis was performed using the MEME suite ([@bib2]). Briefly, Analysis of Motif Enrichment (AME) for canonical motifs was performed in parallel to de novo motif identification with Discriminative Regular Expression Motif Elicitation (DREME) using the central 200 bp of OCT4 peaks. Putative de novo motifs were further subjected to CentriMo analysis to identify motifs that were enriched for the centre of OCT4 peaks. OCT4 peaks were annotated as putative promoters or putative distal regulatory elements in a manner similar to that described previously ([@bib29]), using the relative and absolute coverage of H3K4me3 (a promoter-associated modification; [@bib82]) and H3K4me1 (associated with distal regulatory elements; [@bib75]). Transcription factor peaks with different characteristics were analysed using the GREAT package ([@bib47]), in particular to extract information regarding developmental expression timing from MGI Gene eXpression Database. HOMER2 was used to identify the nearest transcription start sites (TSS) of genes and to perform gene ontology (GO) analysis for differentially regulated genes. Comparison of different remodelling complexes was performed by calculating RPKM for chromatin remodeller ChIP-seq in mouse ESCs across all ATAC peaks (*n* = 76,642) and determining the Pearson correlation with the log2 fold change of *OCT4^cond^* ATAC-seq. Genome-wide correlation of BRG1, OCT4, H3K4me3 and H3K4me1 was generated using the bamCorrelate function of deepTools ([@bib52]).

Accession numbers {#s4-8}
-----------------

ATAC-seq, ChIP-seq and RNA-seq data from the present study are available for download at GSE87822. Previously published datasets used for analysis include mouse ESC H3K4me1 (GSE27844; [@bib75]) and H3K4me3 ChIP-seq (GSE49847; [@bib82]), ENCODE DNase-seq (GSE37074; [@bib82]), ESC chromatin remodeller ChIP-seq (GSE49137, GSE64825; [@bib73]; [@bib18]), iPSC expression data (GSE67462, GSE70022; [@bib11]; [@bib16]), early mouse embryo ATAC-seq (GSE66581; [@bib76]) and DNase-seq (GSE76642; [@bib43]).
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\[Editors' note: this article was originally rejected after discussions between the reviewers, but the authors were invited to resubmit after an appeal against the decision.\]

Thank you for submitting your work entitled \"The pioneer factor OCT4 requires BRG1 to functionally mature gene regulatory elements in mouse embryonic stem cells\" for consideration by *eLife*. Your article has been favorably evaluated by a Senior Editor and three reviewers, one of whom, Irwin Davidson (Reviewer \#1), is a member of our Board of Reviewing Editors.

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that this version of your paper cannot be considered further for publication in *eLife*.

As can be seen from the reviews the referees considered that this was an interesting paper that addresses important questions concerning the regulation of pluripotency and the mechanisms of action of pioneer factors. The referees felt that the experimental system used was elegant and relevant for asking these important questions, yet quite a number of points still need further attention. In particular, it would be important to address the comments of referees 1 and 3 concerning nucleosome positioning with respect to OCT4 binding in presence or absence of BRG1 and provide some experiments to address the kinetics of chromatin reorganisation upon loss of OCT4 and the possible cooperative action of OCT4 with NANOG and SOX2 in BRG1 recruitment. In addition, as stressed by referee 2 the data analyses often lack appropriate statistical and quantitative aspects. Indeed referee 2 points to a number of statements in the text that are not backed up by quantitative analyses. Also discrepancies with previously published data need to be addressed and discussed.

While the large number of outstanding issues raised by the referees preclude simply revision of this version of the paper, we would be happy to consider in the future a new version that addresses the important points raised by the referees.

*Reviewer \#1:*

The study by King and Klose describes the cooperation between OCT4 and BRG1 in establishing accessible chromatin domains that promote binding of OCT4 SOX2 and Nanog to regulatory elements of pluripotency expressed genes in mouse ES cells. They show that OCT4 recruits BRG1 to a large subset of its binding sites to establish an accessible chromatin state and that BRG1 is required for optimal OCT4 occupancy of many of its binding sites together with SOX2 and Nanog. Altogether the results are well presented and constitute an important insight into how OCT4 and BRG1 cooperate to promote transcription factor occupancy and pluripotency. Nevertheless several issues can be addressed.

The major outstanding issue in this study is mechanistically how do OCT4 and BRG1 render the chromatin accessible, what does accessibility really mean? The study uses ATAC-seq as a measure for chromatin accessibility, but as the paper describes OCT4-BRG1 cooperation it is maybe important to go one step further and analyse more precisely how this cooperation affects nucleosome positioning. Can the authors describe how loss of OCT4 or BRG1 affects nucleosome positioning? Can they show that OCT4 and BRG1 cooperate to generate a nucleosome-depleted region to which combinations of OCT4, SOX2 and Nanog bind? When either OCT4 or BRG1 are depleted does this affect nucleosome positioning in similar or different ways? According to the model of pioneer factors proposed in this paper, in absence of BRG1, OCT4 should bind regions occupied by nucleosomes that are displaced when BRG1 is present. Can the authors use the ATAC-seq data to map nucleosome positioning, if not perhaps they should perform Mnase mapping of nucleosome positioning in presence or absence of OCT4 and/or BRG1 to assess how positioning is altered and show that upon BRG1 recruitment critical nucleosomes are displaced to reveal the OCT4, SOX2 and Nanog binding sites.

In [Figure 2B](#fig2){ref-type="fig"} it seems that BRG1 binds at the center of the ATAC peak, but where does it bind relative to OCT4. [Figure 4F](#fig4){ref-type="fig"} gives the impression that OCT4 binding exactly co-localizes with BRG1 implying either that OCT4 binds on the nucleosome, or if OCT4 binds nucleosome depleted regions, then it means BRG1 does not bind the nucleosome, but binds OCT4? Can the authors comment on this and provide further insights into how the data should be interpreted?

*Reviewer \#2:*

The authors use an elegant system to show that OCT4 leads to increases in chromatin accessibility in a manner partly dependent on BRG1. This leads to co-binding of another key ESC TF -- SOX2. The authors further demonstrate that OCT4-BRG1 crosstalk is important for proper ESC gene expression. The manuscript is well written, well organized and clearly focuses on an important event in stem cell biology. An important conclusion from the data is that some pioneer factors need chromatin remodelers to exert their \'pioneering\' activity and maintain pluripotency. However, it seems that the main novelty here is the genome-wide experiments when combined with the control of OCT4 and BRG1 expression in ESCs. Previous studies (cited in the manuscript) already show some aspects that are also presented in this study (link between OCT4 and BRG1, OCT4 leading to more accessible chromatin environment in multipotent cells, reliance of OCT4 on chromatin remodelers etc.).

1\) The authors limit their study to the first 24 Hrs. of Brg1 knockdown, which restricts the ability to observe its actual effects on the maintenance of pluripotency. The authors make the conclusion that Brg1-bound enhancers regulate the pluripotency network. The authors should explore how Brg1 knock down affects pluripotency over the several days necessary to observe or not maintenance of ESCs or evidence of differentiation.

2\) The authors use heatmaps throughout the manuscript. In the cases listed below, heatmaps are insufficient to support the claims raised by the authors. A quantitative analysis including statistics is needed.

A\) [Figure 1H](#fig1){ref-type="fig"}: This is an uncommon way of showing an association between gene expression and TF binding. The authors should try to link these two events in a manner which can be assessed statistically/quantitatively and not only visually (e.g. box plot, binned bar plot of number of sites as a function of distance from TSS etc.).

B\) [Figure 4B](#fig4){ref-type="fig"}: in the text (subsection 2 BRG1 supports transcription factor binding at distal gene regulatory elements") the authors state that they found \'significant reductions in OCT4 binding at the majority (60%) of distal OCT4 targets following BRG1 removal\'. How is that quantified? What is the cutoff criteria for calling a site BRG1-dependent or BRG1-independent? Heatmap analysis is insufficient to determine this.

C\) [Figure 4D](#fig4){ref-type="fig"}, subsection "Gene expression defects in the absence of BRG1 are linked to altered transcription factor binding", see comment 2A.

D\) [Figure 5A](#fig5){ref-type="fig"}, subsection "BRG1-dependency reveals distinct modes of OCT4 function at distal regulatory elements during reprogramming and development", last paragraph, see comment 2A.

3\) Subsection "BRG1 is required to create accessible chromatin at OCT4 target sites in ESCs". [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}: in the text the authors state that \'reductions in chromatin accessibility resulting from the loss of either OCT4 or BRG1 were \'highly similar\'. However, the Venn diagram shows that only half of sites overlap. Moreover, the scatter plot seems to show only weak correlation. Importantly, the R^2^ is not presented so there is no way to evaluate the authors\' statement.

4\) Subsection "The pioneer factor OCT4 binds distal regulatory sites in pluripotent cells that would otherwise be inaccessible", first paragraph. The authors need to provide more detail in the text and figure legends regarding the called Oct4 peaks ([Figure 1C, F](#fig1){ref-type="fig"}) as well as what the exact chromatin signature is being used as a marker for distal regulatory elements ([Figure 1D](#fig1){ref-type="fig"}). Some of the above is summarized in the Methods but it should also be detailed in the main text/legends. Also, does motif analyses show an Oct4 motif enriched at these binding sites? What percentage of sites contain the motif, how strong is the enrichment of the motif?

5\) Subsection "The pioneer factor OCT4 binds distal regulatory sites in pluripotent cells that would otherwise be inaccessible". The reference to \"modest chromatin alterations\" is ambiguous; a more specific description or quantitative comparison between these data and the cited papers is needed.

6\) Subsection "BRG1 is required to create accessible chromatin at OCT4 target sites in ESCs". In [Figure 2G](#fig2){ref-type="fig"}, the authors need to show the Brg1 ChIP-seq heat map with Tamoxifen treatment as they did with Oct4 (+Dox) in [Figure 1F](#fig1){ref-type="fig"}. Also, are these sites the same and in the same order as the Oct4 sites in [Figure 1F](#fig1){ref-type="fig"}?

7\) Subsection "OCT4 establishes chromatin accessibility by recruiting BRG1 to chromatin". [Figure 3D](#fig3){ref-type="fig"}: the correlation between the reduction in ATAC and BRG1 signals is weak (R^2^=0.33) and not \'very good\' or \'high\' as stated in the main text and the legend, respectively. This should be more carefully phrased. Also, the authors should reconcile the reason for the weak correlation.

8)Subsection 2 BRG1 supports transcription factor binding at distal gene regulatory elements". In [Figure 3B](#fig3){ref-type="fig"}, are the Oct4 Chip sites in the conditional Oct4 cell line (untreated) the same in the untreated conditional Brg1 cell line? Again, the authors should use the same sites as those shown in [Figure 1F](#fig1){ref-type="fig"}. A scatter plot of the Oct4 ChIPs from these two cell lines would be good in a supplementary figure.

9\) Subsections "BRG1 supports transcription factor binding at distal gene regulatory elements" and "Gene expression defects in the absence of BRG1 are linked to altered transcription factor binding". What is meant by \"functionally mature\" TF binding events?

10\) Subsection "BRG1-dependency reveals distinct modes of OCT4 function at distal regulatory elements during reprogramming and development", last paragraph. In [Figure 5C](#fig5){ref-type="fig"}, the differences between the Brg1 dependent and independent Oct4 sites are minimal over the development time frame.

*Reviewer \#3:*

In this manuscript King and Klose describe that in mouse ES cells the binding of BRG1, a known as a subunit of the chromatin remodelling BAF complexes, is dependent on the presence of pluripotency factor OCT4. They also show that the presence of OCT4 at its binding sites is required for the binding of SOX2 and NANOG. In reverse experiments the authors find that the binding of OCT4 to the chromatin in ES cells is dependent on the presence of BRG1. From these and other experiments the authors conclude that their experiments reveal \"a distinct requirement for a chromatin remodeller in shaping the activity of the pioneer factor OCT4 and regulating the pluripotency network\".

1\) From the presented experiments it seems that the BRG1/BAF complex is as much as a \"pioneer\" factor as is OCT4. In fact, the Schöler lab has shown (see Singhal et al. 2010) that the BAF complex is binding before OCT4 and Sox2 to the ES specific genes. Thus, the authors need to revise their ideas of OCT4 being a pioneer factor throughout the whole manuscript.

2\) The authors should carry out ChIP-seq with a second subunit of the BAF complex to be able to show that the effects they see with BRG1 are indeed due to the BAF ATP dependent remodelling complex(es).

3\) In the OCT4 knock down experiments the authors carry out ATAC-seq, Oct4, Sox2, Nanog and Brg1 ChIP-seqs, however in the BRG1 knock down conditions they carry out ATAC-seq, Oct4, Sox2, and Brg1 ChIP-seqs, but not Nonog ChIP-seq. Why? Is it possible that actually Nanog and may be Sox2 are recruiting Oct4 and Brg1/BAF complex to these sites?

4\) To resolve these issues, the authors should carry out time scale experiments to test which factor(s) is leaving the first from the Oct4 occupied sites after Oct4 knock-down.

5\) The analyses of Oct4 or Brg1 regulated genes in [Figure 4D](#fig4){ref-type="fig"} do not give the impression that these factors regulate the same subset of genes in spite of the fact that very often they seem to bind to the same sites. How can this be explained? Is it possible that Oct4 (or BRG1) are not regulating the analysed nearby genes?

10.7554/eLife.22631.041

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

*\[...\] Reviewer \#1:*

*\[...\] The major outstanding issue in this study is mechanistically how do OCT4 and BRG1 render the chromatin accessible, what does accessibility really mean? The study uses ATAC-seq as a measure for chromatin accessibility, but as the paper describes OCT4-BRG1 cooperation it is maybe important to go one step further and analyse more precisely how this cooperation affects nucleosome positioning. Can the authors describe how loss of OCT4 or BRG1 affects nucleosome positioning? Can they show that OCT4 and BRG1 cooperate to generate a nucleosome-depleted region to which combinations of OCT4, SOX2 and Nanog bind? When either OCT4 or BRG1 are depleted does this affect nucleosome positioning in similar or different ways? According to the model of pioneer factors proposed in this paper, in absence of BRG1, OCT4 should bind regions occupied by nucleosomes that are displaced when BRG1 is present. Can the authors use the ATAC-seq data to map nucleosome positioning, if not perhaps they should perform Mnase mapping of nucleosome positioning in presence or absence of OCT4 and/or BRG1 to assess how positioning is altered and show that upon BRG1 recruitment critical nucleosomes are displaced to reveal the OCT4, SOX2 and Nanog binding sites.*

We agree with the reviewer it is useful to go a step further and define more precisely how the cooperation between OCT4 and BRG1 affects nucleosome occupancy and positioning at OCT4 target sites. Therefore, we have now performed a new set of analyses on the OCT4^cond^ and Brg1^fl/fl^ ATAC-seq datasets using the NucleoATAC analysis approach (Schep et al., 2015) to measure nucleosome signal in the presence or absence of OCT4/BRG1. In wild type cells, a nucleosome-depleted region is clearly evident at OCT4 binding sites, as demonstrated by the reduced nucleosome signal at the centre of the OCT4 peak compared to neighbouring regions ([Figure 1H](#fig1){ref-type="fig"} and [Figure 4A](#fig4){ref-type="fig"}). Importantly, OCT4 and the BRG1/BAF complex are enriched within this nucleosome-depleted site (also see response to Point 2, and [Figure 4A](#fig4){ref-type="fig"}). We then compared how removal of OCT4 or BRG1 affected the nucleosome-depleted state at OCT4 target sites. This analysis revealed widespread increases in nucleosome signal at sites where OCT4 binding is required for chromatin accessibility following OCT4 removal ([Figure 1H](#fig1){ref-type="fig"}). In contrast, OCT4 target sites where OCT4 is not required for accessibility (i.e. OCT4-independent) ([Figure 1H](#fig1){ref-type="fig"}) remained depleted of nucleosome signal, suggesting that chromatin accessibility measured by ATAC-seq may directly reflect the underlying nucleosome occupancy. Therefore, OCT4-dependent processes play a central role at the majority of OCT4 binding sites in shaping accessibility and displacing nucleosomes. Importantly, when we examined changes in nucleosome signal in the BRG1-depleted cells at OCT4 bound sites ([Figure 3](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) there was no longer the same extent of nucleosome depletion. This is consistent with BRG1 cooperating with OCT4 to establish chromatin accessibility/nucleosome depletion at OCT4 target sites. Intriguingly, sites that retained OCT4 binding in the absence of BRG1 (BRG1-independent OCT4 targets) remained depleted of nucleosomes ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}), suggesting that BRG1-independent activities function to define accessibility and nucleosome-depletion at these sites. Together, these observations demonstrate that BRG1-dependent OCT4 targets (which represent the majority of OCT4 sites) rely on both OCT4 binding and BRG1 to create accessible chromatin and to displace nucleosomes.

We now describe these important new observations in the subsections "The pioneer factor OCT4 binds distal regulatory sites in pluripotent cells that would otherwise be inaccessible", last paragraph, "BRG1 is required to create accessible chromatin at OCT4 target sites in ESCs", and "BRG1 supports transcription factor binding at distal gene regulatory elements".

*In [Figure 2B](#fig2){ref-type="fig"} it seems that BRG1 binds at the center of the ATAC peak, but where does it bind relative to OCT4. [Figure 4F](#fig4){ref-type="fig"} gives the impression that OCT4 binding exactly co-localizes with BRG1 implying either that OCT4 binds on the nucleosome, or if OCT4 binds nucleosome depleted regions, then it means BRG1 does not bind the nucleosome, but binds OCT4? Can the authors comment on this and provide further insights into how the data should be interpreted?*

We have now examined the localisation of OCT4 and BRG1 in more detail using high-resolution metaplots (10bp resolution) and compared this to nucleosome signal at OCT4-bound sites (see point 1). This analysis revealed that OCT4 and BRG1/BAF co-localise within a very narrow nucleosome-depleted region at the centre of OCT4 binding sites ([Figure 4A](#fig4){ref-type="fig"}). As suggested by the reviewer, this appears to be consistent with OCT4-dependent recruitment of BRG1 to its target sites. The fact that OCT4 can bind nucleosomal DNA (Soufi et al., 2012, Soufi et al., 2015) and is responsible for recruiting BRG1 to create accessible and nucleosome-depleted chromatin at most of its target sites ([Figures 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}) is also in fitting with the assisted loading model for transcription factor binding (Voss and Hager, 2014, Swinstead et al., 2016). This model invokes a process whereby transcription factor-dependent binding to nucleosomal DNA (i.e. OCT4) supports recruitment of remodelling activities (i.e. BRG1) to create accessible chromatin that supports further transcription factor binding/co-binding (OCT4/SOX2/NANOG) events. However, we would like to point out that despite the apparent nucleosome-depletion at OCT4 bound sites, we cannot exclude the possibility that OCT4/BRG1 remains bound to an unstable nucleosome during the process of creating local accessibility at target sites (Ishii et al., 2015, Voong et al., 2016). Nevertheless, the high degree of co-localization of OCT4 and BRG1 is a consistent model of OCT4-dependent recruitment of BRG1 to chromatin, where it appears necessary to maintain a nucleosome-depleted state at OCT4 target sites (see response to Point 1). We have emphasized and clarified these points in the subsection "OCT4 establishes chromatin accessibility by recruiting BRG1 to chromatin".

*Reviewer \#2:*

*The authors use an elegant system to show that OCT4 leads to increases in chromatin accessibility in a manner partly dependent on BRG1. This leads to co-binding of another key ESC TF -- SOX2. The authors further demonstrate that OCT4-BRG1 crosstalk is important for proper ESC gene expression. The manuscript is well written, well organized and clearly focuses on an important event in stem cell biology. An important conclusion from the data is that some pioneer factors need chromatin remodelers to exert their \'pioneering\' activity and maintain pluripotency. However, it seems that the main novelty here is the genome-wide experiments when combined with the control of OCT4 and BRG1 expression in ESCs. Previous studies (cited in the manuscript) already show some aspects that are also presented in this study (link between OCT4 and BRG1, OCT4 leading to more accessible chromatin environment in multipotent cells, reliance of OCT4 on chromatin remodelers etc.).*

We thank the reviewer for their kind words regarding our manuscript and we agree that our study addresses an important event in stem cell biology. As pointed out by the reviewer, several previous studies have touched on aspects of OCT4 and BRG1 function related to our study. However, in many cases these studies have focused on a small number of genes, have been performed in different pluripotent cell types (ESCs, embryonal carcinoma, iPSCs), and often come to differing conclusions making it difficult to grasp the scale, validity, and relevance of these often isolated observations. For example, it has remained elusive how OCT4 engages with the thousands of distal regulatory sites it binds in the ESC genome and how this is related to its proposed role as a pioneer transcription factor. In particular, previous studies examining the relationship between OCT4 binding and chromatin accessibility/nucleosome positioning have not addressed how OCT4 transitions inaccessible chromatin into functionally active and accessible regulatory elements required for gene regulation (see response to Point 5 for details on these studies). Furthermore, the link between BRG1 and OCT4 has largely stemmed from simple biochemical immunoprecipitation analysis (Pardo et al., 2010, van den Berg et al., 2010, Ding et al., 2012), with the functional relevance of this proposed interaction remaining unclear.

Here we have taken a systematic and genome-wide approach to address how OCT4 engages with the genome in mouse ESCs and demonstrate a defined role for BRG1 in shaping transcription factor binding, chromatin accessibility and gene regulatory function. We believe this encompasses an important step forward for understanding OCT4 function in ESCs. Furthermore, we provide new evidence that OCT4s function as a pioneer factor relies on an assisted loading type mechanism that utilizes the function of chromatin remodelling machines, which to our knowledge has not been previously proposed. We believe these important and novel discoveries will be well received and highly cited by the readership of *eLife*.

*1) The authors limit their study to the first 24 Hrs. of Brg1 knockdown, which restricts the ability to observe its actual effects on the maintenance of pluripotency. The authors make the conclusion that Brg1-bound enhancers regulate the pluripotency network. The authors should explore how Brg1 knock down affects pluripotency over the several days necessary to observe or not maintenance of ESCs or evidence of differentiation.*

A central goal of our study was to understand in molecular detail, at the genome-scale, how OCT4 interacts with and functions on the genome to orchestrate the pluripotent ESC state, something that in our view is still poorly understood (which we now highlight in the subsection "BRG1 is required to create accessible chromatin at OCT4 target sites in ESCs"). In doing so, we have purposely limited our analysis to time points following genetic ablation of OCT4 and BRG1 that are sufficient to allow protein loss, but where cells still exist in a state that is morphologically and biochemically ESC-like ([Figure 1A, B](#fig1){ref-type="fig"} and [Figure 3F, G](#fig3){ref-type="fig"}). Our rationale for exploiting this approach was as a means to define the molecular mechanisms that support how OCT4 and other pluripotency-associated transcription factors (SOX2 and NANOG) recognize and regulate the pluripotent ESC genome. This revealed that BRG1 is required for normal OCT4/SOX2/NANOG engagement with the ESC genome and to functionally mature distal regulatory elements in controlling gene expression. As the reviewer correctly points out, these observations are important for understanding how the pluripotent state is lost after prolonged BRG1 depletion, which has been the focus of previous studies (Ho et al., 2009, Kidder et al., 2009, Zhang et al., 2014). Therefore, in the context of our defined questions about the molecular mechanisms by which OCT4 and BRG1 cooperate to interact with and regulate the pluripotent genome, it seems unlikely that additional insight will be gained from extending our analysis to later time points where differentiation has ensued.

2\) The authors use heatmaps throughout the manuscript. In the cases listed below, heatmaps are insufficient to support the claims raised by the authors. A quantitative analysis including statistics is needed.

We agree that heatmaps by themselves do not provide any quantitative or statistical support. However, they do provide an intuitive way for non-specialists who will read the manuscript in *eLife* to appreciate the striking reductions and trends in our ATAC-seq, ChIP-seq and RNA-seq datasets. Importantly, in parallel to these heatmap visualisations, we performed robust statistical analyses on all of the datasets presented in heatmaps in the original version of the manuscript. For example, all genomic experiments were performed in biological triplicate and differential transcription factor binding or accessibility was identified and statistically validated using the DiffBind package (Stark and Brown, 2011), with significance being achieved when a FDR \< 0.05 and a fold change \> 1.5-fold was realized (detailed in the subsection "Differential binding and gene expression analysis" in the Materials and methods). We acknowledge that these statistical measures were not highlighted sufficiently in the original submission, and have therefore included additional analyses and figures throughout the revised manuscript that provide a more detailed and quantitative interrogation of the genomic data. While these analyses have undoubtedly increased the statistical robustness of our study, we would like to stress that our interpretation of the data remains essentially unchanged from the original manuscript. Precise details of these additional analyses and figures are included below.

*A) [Figure 1H](#fig1){ref-type="fig"}: This is an uncommon way of showing an association between gene expression and TF binding. The authors should try to link these two events in a manner which can be assessed statistically/quantitatively and not only visually (e.g. box plot, binned bar plot of number of sites as a function of distance from TSS etc.).*

We have now carried out additional quantitative and statistical analysis to reinforce the observation that reductions in chromatin accessibility and transcription factor binding associated with the loss of OCT4 is linked to reduced expression of nearby genes (see [Figure 2E-G](#fig2){ref-type="fig"} in revised manuscript). Firstly, we separated the OCT4-bound sites into those that require OCT4 for accessibility (OCT4-dependent) and those that do not (OCT4-independent) (DiffBind FDR \< 0.05; fold change \> 1.5). We then used box plots to examine the log2 fold changes in expression of the closest genes ([Figure 2E](#fig2){ref-type="fig"}). This revealed that genes in close proximity to OCT4-dependent regulatory elements are significantly more likely to exhibit reductions in gene expression than genes located near OCT4 bound sites that do not rely on OCT4 for accessibility (p \< 7.6 × 10^-43^). Secondly, we identified genes that are significantly down-regulated in the OCT4-depleted ESCs (DESeq2 FDR \< 0.05; fold change \> 1.5). We then compared the OCT4 target sites for which the nearest gene shows such a significant reduction in expression (OCT4-dependent expression) with the OCT4 targets sites that show significant reductions in accessibility (OCT4-dependent accessibility). Through this analysis, we observe that the majority of significant reductions in gene expression are associated with significant reductions in chromatin accessibility at nearby OCT4 target sites ([Figure 2F](#fig2){ref-type="fig"}). As expected, many OCT4-dependent accessibility changes were not associated with changes in gene expression, which may reflect redundancy with other distal regulatory elements, regulation of non-proximal genes, or non-functional OCT4 binding sites. Finally, to examine whether the loss of chromatin accessibility at distal OCT4 bound sites is linked to expression changes of nearby genes, we compared the distance to the nearest down-regulated TSS from OCT4 peaks with or without OCT4-dependent accessibility ([Figure 2G](#fig2){ref-type="fig"}). This nicely illustrated that OCT4-bound regulatory elements that lose accessibility following removal of OCT4 are closer (median 16.2 kb) to downregulated genes than those that do not rely on OCT4 for accessibility (median 125.4 kb) (p \< 4.2 × 10^-147^). Together these new statistical and quantitative analysis support our previous conclusions that OCT4 plays an essential role in determining regulatory element accessibility and function, which is important for the normal expression of nearby genes associated with the pluripotency transcriptional network.

The description and discussion of these new analyses is included in the last paragraph of the subsection "OCT4 supports transcription factor binding at distal regulatory elements to regulate pluripotency-associated genes".

*B) [Figure 4B](#fig4){ref-type="fig"}: in the text (subsection 2 BRG1 supports transcription factor binding at distal gene regulatory elements") the authors state that they found \'significant reductions in OCT4 binding at the majority (60%) of distal OCT4 targets following BRG1 removal\'. How is that quantified? What is the cutoff criteria for calling a site BRG1-dependent or BRG1-independent? Heatmap analysis is insufficient to determine this.*

To identify and quantify sites that have significant reductions in OCT4 binding following BRG1 removal we used the DiffBind package with a significant change in OCT4 binding being achieved when a FDR \< 0.05 and a fold change \> 1.5-fold was observed from biological triplicate experiments. This statistical analysis revealed that 60% of OCT4 bound distal sites showed significant reductions in OCT4 binding following removal of BRG1. In addition to stating this value in text, we have now also included a pie chart for this and similar statistical analysis of SOX2 and NANOG binding in [Figure 5C](#fig5){ref-type="fig"}that better convey this observation.

However, we were conscious in reflection that one issue associated with using this binary segregation of affected/unaffected sites is that it relies on a somewhat arbitrary user defined thresholds (FDR \< 0.05 and a fold change \> 1.5-fold) which can lead to a range of affected sites that fall just below the fold change threshold being considered unaffected (false negatives). In subsequent visualisation and analysis this can cloud one's appreciation of the features associated with BRG1 dependency. To overcome this limitation and focus on the clearest BRG1 dependencies, in the revised manuscript we have stratified OCT4 targets into the 20% of sites that were least dependent on BRG1 (BRG1-independent) and compared these to the 20% of sites that were most dependent on BRG1 (BRG1-dependent). This now allows the reader to more clearly appreciate how BRG1 contributes to a series of features associated with OCT4 target sites in [Figures 5D, G](#fig5){ref-type="fig"} and [Figure 6](#fig6){ref-type="fig"}.

To clarify this for the reader we have highlighted the distinction between these two strategies in the figure legends and in the subsection "BRG1 supports transcription factor binding at distal gene regulatory elements".

*C) [Figure 4D](#fig4){ref-type="fig"}, subsection "Gene expression defects in the absence of BRG1 are linked to altered transcription factor binding", see comment 2A.*

We have now further explored the relationship between altered transcription factor binding and gene expression in the BRG1-depleted ESCs. In new analyses included in [Figure 5](#fig5){ref-type="fig"} and [Figure 5---figure supplement 4](#fig5s4){ref-type="fig"} we have examined the expression changes of genes in close proximity to OCT4 bound sites that have different requirements for BRG1 in OCT4 occupancy ([Figure 5F](#fig5){ref-type="fig"}) and quantified the trend observed in the original heatmap (previously [Figure 4D](#fig4){ref-type="fig"}, now [Figure 5E](#fig5){ref-type="fig"}). This revealed that sites that lose OCT4 are more likely to experience reductions in expression of nearby genes ([Figure 5F, G](#fig5){ref-type="fig"}). In contrast, sites that retain or display increases in OCT4/SOX2/NANOG (BRG1-independent sites; see metaplot in [Figure 5D](#fig5){ref-type="fig"}) are associated with increases in gene expression ([Figure 5F, G](#fig5){ref-type="fig"}). Furthermore, we have quantified the changes in transcription factor binding at distal OCT4 target sites (box plots) in close proximity to the genes with altered gene expression ([Figure 5H](#fig5){ref-type="fig"}), and confirm that genes with reduced expression are associated with the largest reductions in transcription factor binding at nearby OCT4 target sites. We have also included several genomic snapshots depicting RNA-seq and transcription factor ChIP-seq for exemplary genes which experience reduced, unchanged or increased expression ([Figure 5---figure supplement 4](#fig5s4){ref-type="fig"}). Together these analyses provide additional support to our previous conclusions drawn from the heatmap visualisation that the inability of OCT4 and other transcription factors to interact normally with their target sites in the absence of BRG1 is reflected in changes in nearby gene expression. These additional analyses are presented and discussed in the last paragraph of the subsection "Gene expression defects in the absence of BRG1 are linked to altered transcription factor binding".

*D) [Figure 5A](#fig5){ref-type="fig"}, subsection "BRG1-dependency reveals distinct modes of OCT4 function at distal regulatory elements during reprogramming and development", last paragraph, see comment 2A.*

In [Figure 5A](#fig5){ref-type="fig"} (now [Figure 6A](#fig6){ref-type="fig"} in the revised manuscript), we describe that genes associated with BRG1-dependent OCT4 binding sites appear to be activated later during iPSC reprogramming than genes associated with BRG1-independent OCT4 targets. To extend and strengthen this initial observation, we have performed new quantitative analysis to replace the heatmap visualisation, which we agree was difficult to interpret. In this new analysis ([Figure 6A](#fig6){ref-type="fig"}), we have examined the activation dynamics during iPSC generation of genes that require OCT4 for their normal expression in embryonic stem cells (OCT4-dependent genes), and compared genes associated with BRG1-dependent or BRG1-independent OCT4 binding. By quantifying log2FC of gene expression, we demonstrate that genes associated with BRG1-independent OCT4 binding are activated earlier during reprogramming than genes associated with BRG1-dependent OCT4 binding, in fitting with our original observations. Statistical confidence is provided by the 95% confidence intervals visualised on these plots, and we have now performed this analysis on two independent iPSC reprogramming RNA-seq datasets (Chen et al., 2016, Cieply et al., 2016). This provides new quantitative support that BRG1-independent OCT4 binding is associated with early gene activation during reprogramming, while genes associated with BRG1-dependent OCT4 binding are activated later.

*3) Subsection "BRG1 is required to create accessible chromatin at OCT4 target sites in ESCs". [Figure 2figure supplement 1](#fig2s1){ref-type="fig"}: in the text the authors state that \'reductions in chromatin accessibility resulting from the loss of either OCT4 or BRG1 were \'highly similar\'. However, the Venn diagram shows that only half of sites overlap. Moreover, the scatter plot seems to show only weak correlation. Importantly, the R^[@bib3]^ is not presented so there is no way to evaluate the authors\' statement.*

Having identified a link between BRG1 binding and OCT4-dependent chromatin accessibility ([Figure 3A-D](#fig3){ref-type="fig"}), it was imperative that we directly examine whether BRG1 contributed to chromatin accessibility at OCT4 target sites. Genomic snapshots ([Figure 3H](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}), heatmap visualisation ([Figure 3I](#fig3){ref-type="fig"}), and new metaplot visualisation ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}) illustrate that BRG1 clearly plays a widespread role in maintaining normal chromatin accessibility at OCT4 bound sites. When we compared the significant changes (DiffBind FDR \< 0.05; fold change \> 1.5) in chromatin accessibility following BRG1 removal with the significant changes in chromatin accessibility following OCT4 removal, there was a substantial, but not complete overlap between OCT4-dependent accessibility and BRG1-dependent accessibility as highlighted by the reviewer. However, this Venn diagram analysis was based on sites that had statistically significant alterations in binding that were constrained by user defined fold change thresholds. One limitation of this type of approach is that fold change thresholds can overlook affected sites that fall below the user defined threshold (false negatives) as discussed above in reviewer 2 -- Point 2B. Therefore, the original Venn diagram may not have done justice to the breadth of sites that show related alterations in accessibility following OCT4 and BRG1 removal. Therefore, to examine this relationship in more detail we have now carried out unbiased clustering analysis of OCT4-dependent sites based on log2FC ATAC signal in the Brg1^fl/fl^ and OCT4^cond^ cells. This illustrates that chromatin accessibility at 76% of OCT4 targets sites relies on BRG1 (see cluster 1, [Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}). Furthermore, even sites which are classified as BRG1-independent, still display some reductions in ATAC-seq signal (see cluster 2, [Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}), consistent with decreased chromatin accessibility at OCT4 targets sites in the absence of BRG1.

However, it is clear that the reduction in ATAC-seq signal observed at individual OCT4 target sites following BRG1 removal does not always correlate precisely with the reduction in ATAC-seq signal following OCT4 removal. This is evident from the scatterplot in [Figure 3---figure supplement 1F](#fig3s1){ref-type="fig"} (with R^2^ and cor values now included). However, this is actually what we expected based on the heatmap visualisation, as it is clear that not all ATAC-seq signal at OCT4 target sites results directly from BRG1 activity. We suspect that this is due in part to transcription factor binding which is retained at some sites following BRG1 depletion ([Figure 5](#fig5){ref-type="fig"}). Nevertheless, our previous and new analysis clearly demonstrates a widespread role for OCT4 in targeting BRG1 in ESCs ([Figure 4](#fig4){ref-type="fig"}), with the majority of these sites requiring BRG1 to maintain normal chromatin accessibility ([Figure 3](#fig3){ref-type="fig"}).

We have included these new analyses into a new supplementary figure ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) and discuss the above points in the subsection "BRG1 is required to create accessible chromatin at OCT4 target sites in ESCs"

*4) Subsection "The pioneer factor OCT4 binds distal regulatory sites in pluripotent cells that would otherwise be inaccessible", first paragraph. The authors need to provide more detail in the text and figure legends regarding the called Oct4 peaks ([Figure 1C, F](#fig1){ref-type="fig"}) as well as what the exact chromatin signature is being used as a marker for distal regulatory elements ([Figure 1D](#fig1){ref-type="fig"}). Some of the above is summarized in the Methods but it should also be detailed in the main text/legends.*

As suggested by the reviewer we have now clarified the chromatin signature used to annotate OCT4 binding sites as either distal regulatory element or promoters. This description is now included in both the main text and in the figure legend (see subsections "The pioneer factor OCT4 binds distal regulatory sites in pluripotent cells that would otherwise be inaccessible", first paragraph, and "Functional annotation of transcription factor binding sites"). Briefly, this was achieved by examining the relative enrichment of H3K4me3 (usually associated with promoters) and H3K4me1 (usually associated with distal regulatory elements) at OCT4 bound sites as previously described (Hay et al., 2016). To illustrate the effectiveness of these segregations, we have carried out additional metaplot visualisation of H3K4 modifications and calculated the distance to nearest annotated TSS for each class of site ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

Also, does motif analyses show an Oct4 motif enriched at these binding sites? What percentage of sites contain the motif, how strong is the enrichment of the motif?

Our high confidence OCT4 interval set was generated by identifying OCT4 peaks (using DANPOS2) that lose OCT4 ChIP-seq signal after removal of OCT4. To our knowledge, no other previous OCT4 ChIP-seq analysis has included this important control that ensures that the OCT4 ChIP-seq signal is due to the protein and not due to other non-specific ChIP-seq signal. As suggested by the reviewer we have further characterised this interval set by performing motif enrichment analysis (for both canonical motifs and de novo motif enrichment) at our 15,920 OCT4 peaks using the MEME suite of tools. As expected, this analysis revealed a striking enrichment of the OCT4:SOX2 dual motif sequence, in addition to significant enrichments for the highly similar OCT2 motif and two de novo OCT4 motifs. These motifs are enriched at the peak centre (CentriMO analysis), and 60% of peaks contained at least one of these motifs. This is comparable with other studies for transcription factor motifs and binding (Valouev et al., 2008, Heinz et al., 2010). We have included these new analyses in a new supplementary figure ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) and describe this in the subsections "The pioneer factor OCT4 binds distal regulatory sites in pluripotent cells that would otherwise be inaccessible", first paragraph and "Differential binding and gene expression analysis".

*5) Subsection "The pioneer factor OCT4 binds distal regulatory sites in pluripotent cells that would otherwise be inaccessible". The reference to \"modest chromatin alterations\" is ambiguous; a more specific description or quantitative comparison between these data and the cited papers is needed.*

In this line of the text we are referring to previous studies that have proposed a role for OCT4 in promoting alterations to chromatin but which were limited in their scope, technical approach, rigor or interpretation. For example, Shakya et al. (2015) performed histone H3 ChIP-qPCR at a single OCT4 target (the POU5F1 enhancer) and observed depletion of H3 signal after OCT4 over-expression in differentiated cells. You et al. (2011) observed increased nucleosome occupancy (as measured by M.CviPI digestion efficiency) at two OCT4 targets after OCT4 siRNA in NCCIT embryonic carcinoma cells. In both of these cases, the effects on chromatin accessibility/nucleosome occupancy are appreciable and significant, but these studies are limited in that they examine individual loci and are not directly comparable to our study in ESCs.

Alternatively, two studies have generated genome-wide datasets examining the role of OCT4 in determining chromatin accessibility using different approaches. Chen et al. (2014) perform restriction endonuclease digestion (RED)-seq 5 days after knocking down OCT4 with siRNA in mouse ESCs and observed reduced chromatin accessibility at regulatory elements genome-wide. However, ESCs cells depleted of OCT4 for extended periods of time (i.e. 5 days) differentiate (Niwa et al., 2000), meaning that these observations are of little relevance to understanding the precise contribution of OCT4 to maintenance of the pluripotent state that is the focus of our study. Furthermore, these experiments were only performed in biological singlicate, meaning that interpretations drawn from any comparison with this data would lack experimental, statistical, and quantitative rigor. Lu et al. (2016) perform DNase-seq in the early mouse embryo after ablating OCT4 expression with siRNA at the 8-cell stage. However, as described in the original manuscript, knockdown of OCT4 results in reduced DNase-seq signal at both OCT4-bound and OCT4-negative regulatory elements. We therefore find it difficult to interpret whether the observed effects are driven by OCT4 or are secondary effects associated with alterations in cellular trajectory that would result from removal of OCT4 at this early developmental stage. For these reasons, we find it difficult to make meaningful and quantitative comparisons of these studies with our data. In fact, these studies exemplify a lack of clarity in the current understanding of OCT4s function in shaping chromatin structure and accessibility in the pluripotent state, which was one of the central motivations for our detailed and systematic genome-wide study in ESCs.

Nevertheless, in order to better reflect the conclusions drawn by these previous studies, we have rephrased the sentence originally highlighted by the reviewer with the following text, although do not describe each in detail each for the sake of brevity.

"This is supported by previous studies describing a role for OCT4 in maintaining nucleosome-depleted regions and/or chromatin accessibility at individual loci in pluripotent cells (You et al., 2011, Shakya et al., 2015) or genome-wide (Chen et al., 2014, Lu et al., 2016)."

*6) Subsection "BRG1 is required to create accessible chromatin at OCT4 target sites in ESCs". In [Figure 2G](#fig2){ref-type="fig"}, the authors need to show the Brg1 ChIP-seq heat map with Tamoxifen treatment as they did with Oct4 (+Dox) in [Figure 1F](#fig1){ref-type="fig"}. Also, are these sites the same and in the same order as the Oct4 sites in [Figure 1F](#fig1){ref-type="fig"}?*

We have now performed BRG1 ChIP-seq in the Brg1^fl/fl^ ESCs before and after tamoxifen treatment and have visualised these data by heat mapping as suggested by the reviewer. We have also included genomic snapshots for this BRG1 ChIP-seq data in [Figure 3H](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}. As expected, treatment of the Brg1^fl/fl^ ESCs with tamoxifen results in dramatic reduction in BRG1 ChIP-seq signal at OCT4 target sites. Furthermore, these OCT4 target sites are ranked in the same order as in [Figure 1F](#fig1){ref-type="fig"}. We have adjusted the Figure legend to indicate this.

*7) Subsection "OCT4 establishes chromatin accessibility by recruiting BRG1 to chromatin". [Figure 3D](#fig3){ref-type="fig"}: the correlation between the reduction in ATAC and BRG1 signals is weak (R^2^=0.33) and not \'very good\' or \'high\' as stated in the main text and the legend, respectively. This should be more carefully phrased. Also, the authors should reconcile the reason for the weak correlation.*

In [Figure 3D](#fig3){ref-type="fig"} (now [Figure 4E](#fig4){ref-type="fig"}), we have provided two different measures of statistical confidence, the linear regression co-efficient (R^2^), which represents the goodness of fit between the two variables and Pearson correlation coefficient (cor) to quantify the degree to which these two variables are related. Therefore, the Pearson correlation is 0.57 which we believe represents a good correlation between these two variables given that we are comparing two different genomic assays (ChIP-seq and ATAC-seq) that have very different inherent features (i.e. dynamic range and signal to noise). Furthermore, we have now performed ChIP-seq for an additional BAF subunit (SS18), and this has revealed similar trend but with an appreciably higher correlation (cor = 0.80). We suspect this may reflect the better signal-to-noise of the SS18 ChIP-seq compared to the BRG1 ChIP-seq. We have included this new analysis in the manuscript ([Figure 4E](#fig4){ref-type="fig"}) and have adjusted the language we use in the main text and figure legend to reflect the nature of this correlation more accurately in the subsection "OCT4 establishes chromatin accessibility by recruiting BRG1 to chromatin".

*8) Subsection "BRG1 supports transcription factor binding at distal gene regulatory elements". In [Figure 3B](#fig3){ref-type="fig"}, are the Oct4 Chip sites in the conditional Oct4 cell line (untreated) the same in the untreated conditional Brg1 cell line? Again, the authors should use the same sites as those shown in [Figure 1F](#fig1){ref-type="fig"}. A scatter plot of the Oct4 ChIPs from these two cell lines would be good in a supplementary figure.*

Throughout the manuscript we have used a single OCT4 peak set based on the OCT4 ChIP-seq performed in the OCT4^cond^ ESCs, which is described and characterised in [Figure 1](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}. We have used this peak set in [Figures 1](#fig1){ref-type="fig"}--[4](#fig4){ref-type="fig"}, and a subset of these intervals (only distal regulatory element peaks) for [Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"} where our analysis is focused on distal regulatory elements. As suggested by the reviewer we have compared the wild type OCT4 ChIP-seq from the two different cell lines using a scatterplot and regression/correlation analysis. This confirmed that OCT4 binding is highly similar in the two cell lines. This has now been included in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} and is described in the subsection "BRG1 supports transcription factor binding at distal gene regulatory elements".

*9) Subsections "BRG1 supports transcription factor binding at distal gene regulatory elements" and "Gene expression defects in the absence of BRG1 are linked to altered transcription factor binding". What is meant by \"functionally mature\" TF binding events?*

We have used this term to describe the process by which the initial sampling or binding of OCT4 to inaccessible chromatin is ultimately resolved into the formation of distal regulatory elements with a full complement of transcription factor binding and gene regulatory capacity. Importantly our work demonstrates a clear role for BRG1/BAF in the functional maturation of OCT4 target sites in ESCs. We have clarified this point at various points throughout the manuscript to better reflect this (see subsections "BRG1 supports transcription factor binding at distal gene regulatory elements" and "Gene expression defects in the absence of BRG1 are linked to altered transcription factor binding", last paragraph).

*10) Subsection "BRG1-dependency reveals distinct modes of OCT4 function at distal regulatory elements during reprogramming and development", last paragraph. In [Figure 5C](#fig5){ref-type="fig"}, the differences between the Brg1 dependent and independent Oct4 sites are minimal over the development time frame.*

In [Figure 5C](#fig5){ref-type="fig"} (now [Figure 6C](#fig6){ref-type="fig"} in the revised manuscript), we illustrate that sites that rely on BRG1 for OCT4 binding in ESCs gain accessibility later than BRG1-independent OCT4 binding sites during early mouse development. We have now performed a quantitative analysis that illustrates this point more clearly in [Figure 6D](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}. Firstly, in [Figure 6D](#fig6){ref-type="fig"} we have quantified and plotted the ATAC-seq read density for BRG1-dependent or BRG1-independent OCT4-bound distal regulatory elements as development proceeds to more easily visualise the gains in chromatin accessibility depicted in the metaplots in [Figure 6C](#fig6){ref-type="fig"}. Statistical confidence is provided by the 95% confidence intervals for each group. Secondly, we have performed the identical analysis on a comparable but independently generated DNase-seq dataset in the early mouse embryo ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}; Lu et al., 2016). This revealed the same trend as [Figures 6C and D](#fig6){ref-type="fig"}, strengthening our original observation that BRG1-independent targets become accessible earlier, and BRG1-dependent later, during early mouse development and reprogramming.

*Reviewer \#3:*

\[...\] 1) From the presented experiments it seems that the BRG1/BAF complex is as much as a \"pioneer\" factor as is OCT4. In fact, the Schöler lab has shown (see Singhal et al. 2010) that the BAF complex is binding before OCT4 and Sox2 to the ES specific genes. Thus, the authors need to revise their ideas of OCT4 being a pioneer factor throughout the whole manuscript. \#

From our reading of the Singhal et al. (2010) study we do not find evidence to support the BAF complex functioning as a pioneer factor at target sites prior to OCT4 and SOX2 binding. In fact, binding of the BAF complex was not examined in this study (by ChIP or otherwise). Instead, what the Singhal et al. study demonstrates is that overexpression of BRG1/BAF with the reprogramming factors OCT4, KLF, and SOX2 (OKS) in mouse embryonic fibroblasts increases the efficiency of reprogramming and iPSC formation (now described in the second paragraph of the Discussion). While this clearly indicates that BRG1 is important for the efficiency of OCT4-driven reprogramming, it does not suggest that BRG1 functions as a pioneer factor. This term is usually reserved to describe sequence-specific transcription factors that are capable of binding inaccessible chromatin to establish new functional regulatory elements and drive gene expression (see Magnani et al., 2011, Iwafuchi-Doi and Zaret, 2014, Swinstead et al., 2016). Based on our observations it seems more plausible that the iPSC reprogramming process is potentiated by BAF through its recruitment to regulatory sites via OCT4 in a temporally coincident manner. Indeed, similar conclusions were arrived at in a recently published study examining BRG1 binding during reprogramming (Chronis et al., 2017), which we now cite in the subsection "OCT4 establishes chromatin accessibility by recruiting BRG1 to chromatin". In our view, these observations would exclude BRG1/BAF from being considered as a classical pioneer transcription factor, but instead are consistent with OCT4 recruiting BRG1 to distal regulatory elements as part of an assisted loading mechanism for pioneer transcription factor binding and function as suggested in our original submission.

*2) The authors should carry out ChIP-seq with a second subunit of the BAF complex to be able to show that the effects they see with BRG1 are indeed due to the BAF ATP dependent remodelling complex(es).*

As suggested by the reviewer we have now performed ChIP-seq for SS18, which forms part of the BAF remodelling complex in ESCs and other cell types (Kadoch and Crabtree, 2013), before and after removal of OCT4. In agreement with our BRG1 ChIP-seq analysis, SS18 binding is largely dependent upon OCT4 at OCT4 bound distal regulatory sites ([Figure 4B-E](#fig4){ref-type="fig"}, subsection "OCT4 establishes chromatin accessibility by recruiting BRG1 to chromatin"). Furthermore, the reductions in both BAF subunits correlated with the alterations in chromatin accessibility observed by ATAC-seq ([Figure 4E](#fig4){ref-type="fig"}). This provides new evidence supporting the conclusion that OCT4 recruits the BAF remodelling complexes to chromatin in order to facilitate chromatin accessibility and transcription factor binding.

*3) In the OCT4 knock down experiments the authors carry out ATAC-seq, Oct4, Sox2, Nanog and Brg1 ChIP-seqs, however in the BRG1 knock down conditions they carry out ATAC-seq, Oct4, Sox2, and Brg1 ChIP-seqs, but not Nonog ChIP-seq. Why?*

As suggested by the reviewer we have now performed NANOG ChIP-seq in the Brg1^fl/fl^ ESCs before and after tamoxifen treatment. The effect on NANOG binding following removal of BRG1 is highly similar to SOX2, with sites relying on BRG1 for OCT4 binding displaying reductions NANOG occupancy and sites that retain OCT4 binding displaying maintenance or even increased in NANOG occupancy ([Figure 5A-D](#fig5){ref-type="fig"}). We have now described these observations in the subsection "BRG1 supports transcription factor binding at distal gene regulatory elements".

*Is it possible that actually Nanog and may be Sox2 are recruiting Oct4 and Brg1/BAF complex to these sites?*

It is likely that SOX2 contributes to the occupancy of OCT4 at its binding sites given the previously described co-operative and synergistic DNA binding by OCT4 and SOX2 in vitro (Reményi et al., 2003). However, OCT4 can bind to its target sites on nucleosomal DNA independently of SOX2 (Soufi et al., 2015), suggesting that binding with SOX2 may function to stabilise OCT4 binding as opposed to directing its initial binding. Consistent with these in vitro observations, our in vivo experiments suggest that SOX2 or NANOG are not sufficient to recruit BRG1 as SOX2 and/or NANOG are retained at some target sites following depletion of OCT4, yet BRG1 binding is either completely lost or substantially reduced ([Author response image 1](#fig7){ref-type="fig"}).10.7554/eLife.22631.019Author response image 1.BRG1/BAF occupancy relies upon OCT4 but not SOX2 and NANOG binding.Genomic snapshots of OCT4 targets that retain SOX2 and NANOG binding in the absence of OCT4, but lose BRG1 and SS18 ChIP-seq signal.**DOI:** [http://dx.doi.org/10.7554/eLife.22631.019](10.7554/eLife.22631.019)

*4) To resolve these issues, the authors should carry out time scale experiments to test which factor(s) is leaving the first from the Oct4 occupied sites after Oct4 knock-down.*

We agree that our study, and previous studies, lack the fine scale temporal resolution necessary to determine the kinetics with which altered chromatin accessibility, transcription factor binding and BRG1 chromatin occupancy occur following OCT4 removal. While we are immensely interested in these important questions, the current genetic ablation systems that are available are relatively slow (relying on natural turnover of pre-existing protein, \~24 hours for OCT4 and \~72 hours for BRG1) and asynchronous amongst the cell population. This presents a major technical barrier towards effectively assigning order of events in the type of kinetic experiments proposed by the reviewer. We envisage that addressing these important questions will require the development of rapid and synchronous protein ablations systems, likely degron based, and this remains an important challenge for future studies.

*5) The analyses of Oct4 or Brg1 regulated genes in [Figure 4D](#fig4){ref-type="fig"} do not give the impression that these factors regulate the same subset of genes in spite of the fact that very often they seem to bind to the same sites. How can this be explained?*

We thank the reviewer for raising this important point that we have now clarified with the support by several new analyses. In the absence of BRG1, our observations demonstrate that normal binding of pluripotency transcription factors OCT4, SOX2 and NANOG was disrupted at OCT4-bound distal regulatory elements, suggesting that this may affect expression of the pluripotency-associated transcriptional network. Somewhat surprisingly, previous work did not support a clear correlation between loss of BRG1 and the activity of OCT4 target genes (Ho et al., 2009, Ho et al., 2011, Zhang et al., 2014, Hainer et al., 2015), despite our observations that BRG1 plays an important role in transcription factor binding at many target sites associated with pluripotency-associated genes. However, we also observed that the effect on OCT4, SOX2 and NANOG binding following BRG1 removal varied in magnitude between individual sites with some sites actually displaying increases in transcription factor binding ([Figure 5A-D](#fig5){ref-type="fig"}). We therefore reasoned that transcriptional effects following loss of BRG1 might not precisely correlate with the expression changes following OCT4 removal but may instead be related to alterations in OCT4, SOX2 and NANOG binding at individual sites that we observed in the BRG1-depleted cells. Based on this possibility we examined the relationship between gene expression changes following OCT4 and BRG1 ablation in more detail using unbiased clustering of OCT4-dependent genes based on their expression after removal of BRG1. We identified three separate types of responses; genes that showed reduced expression (28.1%), genes whose expression was unchanged (35.2%), and genes that had increased gene expression (36.7%) ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}). Given that individual distal regulatory elements vary in the requirement for BRG1 in OCT4, SOX2 and NANOG binding, we examined whether expression of associated genes corresponded to the effects on transcription factor binding at associated distal regulatory elements. Importantly, this analysis revealed that the expression of genes associated with sites that rely on BRG1 for OCT4 binding tended to be reduced following deletion of BRG1 ([Figure 5E-H](#fig5){ref-type="fig"}, [Figure 5---figure supplement 4](#fig5s4){ref-type="fig"}). In contrast, genes associated with unchanged or increased OCT4, SOX2 and NANOG binding tended to show increases in expression ([Figure 5E-H](#fig5){ref-type="fig"}, [Figure 5---figure supplement 4](#fig5s4){ref-type="fig"}). Together these observations explain why previous studies have failed to identify a simple relationship between gene expression changes following OCT4 and BRG1 removal and demonstrates that reductions in expression of as subset of OCT4 target genes depends on loss of normal transcription factor binding following BRG1 removal. We now describe these points and additional analyses in the last paragraph of the subsection "Gene expression defects in the absence of BRG1 are linked to altered transcription factor binding".

*Is it possible that Oct4 (or BRG1) are not regulating the analysed nearby genes?*

We used a simple approach based on coupling OCT4-bound distal regulatory elements with the closest TSS in order to examine changes in gene expression with altered chromatin accessibility and transcription factor binding. Therefore, this set of relationships will inevitably not represent the complete set of target genes affected by OCT4 bound distal regulatory elements and will also encompass false positives. However, in the absence of experimentally validated and high resolution genome-wide enhancer-promoter interaction maps we believe this is a reasonable approach that is likely to represent many functionally relevant relationships. Similar approaches have previously been used in genomic studies to broadly examine the function of distal regulatory elements in gene regulation (Kim et al., 2010, Degner et al., 2012).
